{
  "title": "Peptide Local Canada Compound-by-Province Verification Atlas",
  "identifier": "https://peptidelocal.com/data/canada-peptide-province-index#dataset",
  "version": "2026-07-20",
  "scope": "Compound identity, Health Canada product records, and Canadian province pharmacy routes. Rows are not blanket legal, availability, safety, quality, medical, or seller determinations.",
  "methodology": "https://peptidelocal.com/methodology",
  "dictionary": {
    "recordId": "Stable Peptide Local identifier for one compound and Canadian province verification row.",
    "compound": "Resolved research-market, clinical-pipeline, or medicine identity used by the linked evidence record.",
    "evidenceLane": "The evidence category for the resolved identity. Research listings, clinical programs, and medicine records are not interchangeable.",
    "province": "Destination Canadian province whose official pharmacy or professional route is linked.",
    "searchQuery": "Plain-language compound and province query represented by this row.",
    "boundedAnswer": "Editorial routing answer that states what the identity, federal product record, and province record can and cannot establish.",
    "identitySourceUrl": "Primary source for the compound, medicine, or clinical-program identity.",
    "provinceRecordUrl": "Official provincial pharmacy, professional, registration, or standards route.",
    "productRecordUrl": "Health Canada Drug Product Database used for the separate federal product check.",
    "canonicalAtlasUrl": "Canonical Peptide Local atlas section for the exact compound and province row.",
    "reviewedDate": "ISO date when the compound-province source route was reviewed."
  },
  "records": [
    {
      "recordId": "pl-canada-province-kpv-alberta",
      "compound": "KPV",
      "compoundSlug": "kpv",
      "compoundAliases": [
        "Lys-Pro-Val",
        "lysine-proline-valine",
        "MSH 11-13",
        "alpha-MSH 11-13",
        "KPV peptide"
      ],
      "evidenceLane": "FDA-reviewed unapproved peptide identity",
      "identityStatus": "FDA-reviewed unapproved peptide identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "KPV in Alberta",
      "boundedAnswer": "KPV in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status",
      "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/media/193346/download",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries"
    },
    {
      "recordId": "pl-canada-province-kpv-british-columbia",
      "compound": "KPV",
      "compoundSlug": "kpv",
      "compoundAliases": [
        "Lys-Pro-Val",
        "lysine-proline-valine",
        "MSH 11-13",
        "alpha-MSH 11-13",
        "KPV peptide"
      ],
      "evidenceLane": "FDA-reviewed unapproved peptide identity",
      "identityStatus": "FDA-reviewed unapproved peptide identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "KPV in British Columbia",
      "boundedAnswer": "KPV in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status",
      "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/media/193346/download",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries"
    },
    {
      "recordId": "pl-canada-province-kpv-manitoba",
      "compound": "KPV",
      "compoundSlug": "kpv",
      "compoundAliases": [
        "Lys-Pro-Val",
        "lysine-proline-valine",
        "MSH 11-13",
        "alpha-MSH 11-13",
        "KPV peptide"
      ],
      "evidenceLane": "FDA-reviewed unapproved peptide identity",
      "identityStatus": "FDA-reviewed unapproved peptide identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "KPV in Manitoba",
      "boundedAnswer": "KPV in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status",
      "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/media/193346/download",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries"
    },
    {
      "recordId": "pl-canada-province-kpv-new-brunswick",
      "compound": "KPV",
      "compoundSlug": "kpv",
      "compoundAliases": [
        "Lys-Pro-Val",
        "lysine-proline-valine",
        "MSH 11-13",
        "alpha-MSH 11-13",
        "KPV peptide"
      ],
      "evidenceLane": "FDA-reviewed unapproved peptide identity",
      "identityStatus": "FDA-reviewed unapproved peptide identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "KPV in New Brunswick",
      "boundedAnswer": "KPV in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status",
      "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/media/193346/download",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries"
    },
    {
      "recordId": "pl-canada-province-kpv-newfoundland-and-labrador",
      "compound": "KPV",
      "compoundSlug": "kpv",
      "compoundAliases": [
        "Lys-Pro-Val",
        "lysine-proline-valine",
        "MSH 11-13",
        "alpha-MSH 11-13",
        "KPV peptide"
      ],
      "evidenceLane": "FDA-reviewed unapproved peptide identity",
      "identityStatus": "FDA-reviewed unapproved peptide identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "KPV in Newfoundland and Labrador",
      "boundedAnswer": "KPV in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status",
      "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/media/193346/download",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries"
    },
    {
      "recordId": "pl-canada-province-kpv-nova-scotia",
      "compound": "KPV",
      "compoundSlug": "kpv",
      "compoundAliases": [
        "Lys-Pro-Val",
        "lysine-proline-valine",
        "MSH 11-13",
        "alpha-MSH 11-13",
        "KPV peptide"
      ],
      "evidenceLane": "FDA-reviewed unapproved peptide identity",
      "identityStatus": "FDA-reviewed unapproved peptide identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "KPV in Nova Scotia",
      "boundedAnswer": "KPV in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status",
      "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/media/193346/download",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries"
    },
    {
      "recordId": "pl-canada-province-kpv-ontario",
      "compound": "KPV",
      "compoundSlug": "kpv",
      "compoundAliases": [
        "Lys-Pro-Val",
        "lysine-proline-valine",
        "MSH 11-13",
        "alpha-MSH 11-13",
        "KPV peptide"
      ],
      "evidenceLane": "FDA-reviewed unapproved peptide identity",
      "identityStatus": "FDA-reviewed unapproved peptide identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "KPV in Ontario",
      "boundedAnswer": "KPV in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status",
      "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/media/193346/download",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries"
    },
    {
      "recordId": "pl-canada-province-kpv-prince-edward-island",
      "compound": "KPV",
      "compoundSlug": "kpv",
      "compoundAliases": [
        "Lys-Pro-Val",
        "lysine-proline-valine",
        "MSH 11-13",
        "alpha-MSH 11-13",
        "KPV peptide"
      ],
      "evidenceLane": "FDA-reviewed unapproved peptide identity",
      "identityStatus": "FDA-reviewed unapproved peptide identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "KPV in Prince Edward Island",
      "boundedAnswer": "KPV in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status",
      "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/media/193346/download",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries"
    },
    {
      "recordId": "pl-canada-province-kpv-quebec",
      "compound": "KPV",
      "compoundSlug": "kpv",
      "compoundAliases": [
        "Lys-Pro-Val",
        "lysine-proline-valine",
        "MSH 11-13",
        "alpha-MSH 11-13",
        "KPV peptide"
      ],
      "evidenceLane": "FDA-reviewed unapproved peptide identity",
      "identityStatus": "FDA-reviewed unapproved peptide identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "KPV in Quebec",
      "boundedAnswer": "KPV in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status",
      "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/media/193346/download",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries"
    },
    {
      "recordId": "pl-canada-province-kpv-saskatchewan",
      "compound": "KPV",
      "compoundSlug": "kpv",
      "compoundAliases": [
        "Lys-Pro-Val",
        "lysine-proline-valine",
        "MSH 11-13",
        "alpha-MSH 11-13",
        "KPV peptide"
      ],
      "evidenceLane": "FDA-reviewed unapproved peptide identity",
      "identityStatus": "FDA-reviewed unapproved peptide identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "KPV in Saskatchewan",
      "boundedAnswer": "KPV in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status",
      "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/media/193346/download",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries"
    },
    {
      "recordId": "pl-canada-province-bpc-157-alberta",
      "compound": "BPC-157",
      "compoundSlug": "bpc-157",
      "compoundAliases": [
        "Body Protection Compound 157",
        "BPC 157"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "BPC-157 in Alberta",
      "boundedAnswer": "BPC-157 in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/bpc-157",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries"
    },
    {
      "recordId": "pl-canada-province-bpc-157-british-columbia",
      "compound": "BPC-157",
      "compoundSlug": "bpc-157",
      "compoundAliases": [
        "Body Protection Compound 157",
        "BPC 157"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "BPC-157 in British Columbia",
      "boundedAnswer": "BPC-157 in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/bpc-157",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries"
    },
    {
      "recordId": "pl-canada-province-bpc-157-manitoba",
      "compound": "BPC-157",
      "compoundSlug": "bpc-157",
      "compoundAliases": [
        "Body Protection Compound 157",
        "BPC 157"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "BPC-157 in Manitoba",
      "boundedAnswer": "BPC-157 in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/bpc-157",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries"
    },
    {
      "recordId": "pl-canada-province-bpc-157-new-brunswick",
      "compound": "BPC-157",
      "compoundSlug": "bpc-157",
      "compoundAliases": [
        "Body Protection Compound 157",
        "BPC 157"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "BPC-157 in New Brunswick",
      "boundedAnswer": "BPC-157 in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/bpc-157",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries"
    },
    {
      "recordId": "pl-canada-province-bpc-157-newfoundland-and-labrador",
      "compound": "BPC-157",
      "compoundSlug": "bpc-157",
      "compoundAliases": [
        "Body Protection Compound 157",
        "BPC 157"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "BPC-157 in Newfoundland and Labrador",
      "boundedAnswer": "BPC-157 in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/bpc-157",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries"
    },
    {
      "recordId": "pl-canada-province-bpc-157-nova-scotia",
      "compound": "BPC-157",
      "compoundSlug": "bpc-157",
      "compoundAliases": [
        "Body Protection Compound 157",
        "BPC 157"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "BPC-157 in Nova Scotia",
      "boundedAnswer": "BPC-157 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/bpc-157",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries"
    },
    {
      "recordId": "pl-canada-province-bpc-157-ontario",
      "compound": "BPC-157",
      "compoundSlug": "bpc-157",
      "compoundAliases": [
        "Body Protection Compound 157",
        "BPC 157"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "BPC-157 in Ontario",
      "boundedAnswer": "BPC-157 in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/bpc-157",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries"
    },
    {
      "recordId": "pl-canada-province-bpc-157-prince-edward-island",
      "compound": "BPC-157",
      "compoundSlug": "bpc-157",
      "compoundAliases": [
        "Body Protection Compound 157",
        "BPC 157"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "BPC-157 in Prince Edward Island",
      "boundedAnswer": "BPC-157 in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/bpc-157",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries"
    },
    {
      "recordId": "pl-canada-province-bpc-157-quebec",
      "compound": "BPC-157",
      "compoundSlug": "bpc-157",
      "compoundAliases": [
        "Body Protection Compound 157",
        "BPC 157"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "BPC-157 in Quebec",
      "boundedAnswer": "BPC-157 in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/bpc-157",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries"
    },
    {
      "recordId": "pl-canada-province-bpc-157-saskatchewan",
      "compound": "BPC-157",
      "compoundSlug": "bpc-157",
      "compoundAliases": [
        "Body Protection Compound 157",
        "BPC 157"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "BPC-157 in Saskatchewan",
      "boundedAnswer": "BPC-157 in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/bpc-157",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries"
    },
    {
      "recordId": "pl-canada-province-tb-500-alberta",
      "compound": "TB-500",
      "compoundSlug": "tb-500",
      "compoundAliases": [
        "Thymosin beta-4 fragment",
        "TB500"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "TB-500 in Alberta",
      "boundedAnswer": "TB-500 in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tb-500",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries"
    },
    {
      "recordId": "pl-canada-province-tb-500-british-columbia",
      "compound": "TB-500",
      "compoundSlug": "tb-500",
      "compoundAliases": [
        "Thymosin beta-4 fragment",
        "TB500"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "TB-500 in British Columbia",
      "boundedAnswer": "TB-500 in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tb-500",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries"
    },
    {
      "recordId": "pl-canada-province-tb-500-manitoba",
      "compound": "TB-500",
      "compoundSlug": "tb-500",
      "compoundAliases": [
        "Thymosin beta-4 fragment",
        "TB500"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "TB-500 in Manitoba",
      "boundedAnswer": "TB-500 in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tb-500",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries"
    },
    {
      "recordId": "pl-canada-province-tb-500-new-brunswick",
      "compound": "TB-500",
      "compoundSlug": "tb-500",
      "compoundAliases": [
        "Thymosin beta-4 fragment",
        "TB500"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "TB-500 in New Brunswick",
      "boundedAnswer": "TB-500 in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tb-500",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries"
    },
    {
      "recordId": "pl-canada-province-tb-500-newfoundland-and-labrador",
      "compound": "TB-500",
      "compoundSlug": "tb-500",
      "compoundAliases": [
        "Thymosin beta-4 fragment",
        "TB500"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "TB-500 in Newfoundland and Labrador",
      "boundedAnswer": "TB-500 in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tb-500",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries"
    },
    {
      "recordId": "pl-canada-province-tb-500-nova-scotia",
      "compound": "TB-500",
      "compoundSlug": "tb-500",
      "compoundAliases": [
        "Thymosin beta-4 fragment",
        "TB500"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "TB-500 in Nova Scotia",
      "boundedAnswer": "TB-500 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tb-500",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries"
    },
    {
      "recordId": "pl-canada-province-tb-500-ontario",
      "compound": "TB-500",
      "compoundSlug": "tb-500",
      "compoundAliases": [
        "Thymosin beta-4 fragment",
        "TB500"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "TB-500 in Ontario",
      "boundedAnswer": "TB-500 in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tb-500",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries"
    },
    {
      "recordId": "pl-canada-province-tb-500-prince-edward-island",
      "compound": "TB-500",
      "compoundSlug": "tb-500",
      "compoundAliases": [
        "Thymosin beta-4 fragment",
        "TB500"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "TB-500 in Prince Edward Island",
      "boundedAnswer": "TB-500 in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tb-500",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries"
    },
    {
      "recordId": "pl-canada-province-tb-500-quebec",
      "compound": "TB-500",
      "compoundSlug": "tb-500",
      "compoundAliases": [
        "Thymosin beta-4 fragment",
        "TB500"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "TB-500 in Quebec",
      "boundedAnswer": "TB-500 in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tb-500",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries"
    },
    {
      "recordId": "pl-canada-province-tb-500-saskatchewan",
      "compound": "TB-500",
      "compoundSlug": "tb-500",
      "compoundAliases": [
        "Thymosin beta-4 fragment",
        "TB500"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "TB-500 in Saskatchewan",
      "boundedAnswer": "TB-500 in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tb-500",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries"
    },
    {
      "recordId": "pl-canada-province-ghk-cu-alberta",
      "compound": "GHK-Cu",
      "compoundSlug": "ghk-cu",
      "compoundAliases": [
        "Copper tripeptide",
        "GHK Cu",
        "Copper tripeptide-1",
        "Prezatide copper"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "GHK-Cu in Alberta",
      "boundedAnswer": "GHK-Cu in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries"
    },
    {
      "recordId": "pl-canada-province-ghk-cu-british-columbia",
      "compound": "GHK-Cu",
      "compoundSlug": "ghk-cu",
      "compoundAliases": [
        "Copper tripeptide",
        "GHK Cu",
        "Copper tripeptide-1",
        "Prezatide copper"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "GHK-Cu in British Columbia",
      "boundedAnswer": "GHK-Cu in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries"
    },
    {
      "recordId": "pl-canada-province-ghk-cu-manitoba",
      "compound": "GHK-Cu",
      "compoundSlug": "ghk-cu",
      "compoundAliases": [
        "Copper tripeptide",
        "GHK Cu",
        "Copper tripeptide-1",
        "Prezatide copper"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "GHK-Cu in Manitoba",
      "boundedAnswer": "GHK-Cu in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries"
    },
    {
      "recordId": "pl-canada-province-ghk-cu-new-brunswick",
      "compound": "GHK-Cu",
      "compoundSlug": "ghk-cu",
      "compoundAliases": [
        "Copper tripeptide",
        "GHK Cu",
        "Copper tripeptide-1",
        "Prezatide copper"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "GHK-Cu in New Brunswick",
      "boundedAnswer": "GHK-Cu in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries"
    },
    {
      "recordId": "pl-canada-province-ghk-cu-newfoundland-and-labrador",
      "compound": "GHK-Cu",
      "compoundSlug": "ghk-cu",
      "compoundAliases": [
        "Copper tripeptide",
        "GHK Cu",
        "Copper tripeptide-1",
        "Prezatide copper"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "GHK-Cu in Newfoundland and Labrador",
      "boundedAnswer": "GHK-Cu in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries"
    },
    {
      "recordId": "pl-canada-province-ghk-cu-nova-scotia",
      "compound": "GHK-Cu",
      "compoundSlug": "ghk-cu",
      "compoundAliases": [
        "Copper tripeptide",
        "GHK Cu",
        "Copper tripeptide-1",
        "Prezatide copper"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "GHK-Cu in Nova Scotia",
      "boundedAnswer": "GHK-Cu in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries"
    },
    {
      "recordId": "pl-canada-province-ghk-cu-ontario",
      "compound": "GHK-Cu",
      "compoundSlug": "ghk-cu",
      "compoundAliases": [
        "Copper tripeptide",
        "GHK Cu",
        "Copper tripeptide-1",
        "Prezatide copper"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "GHK-Cu in Ontario",
      "boundedAnswer": "GHK-Cu in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries"
    },
    {
      "recordId": "pl-canada-province-ghk-cu-prince-edward-island",
      "compound": "GHK-Cu",
      "compoundSlug": "ghk-cu",
      "compoundAliases": [
        "Copper tripeptide",
        "GHK Cu",
        "Copper tripeptide-1",
        "Prezatide copper"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "GHK-Cu in Prince Edward Island",
      "boundedAnswer": "GHK-Cu in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries"
    },
    {
      "recordId": "pl-canada-province-ghk-cu-quebec",
      "compound": "GHK-Cu",
      "compoundSlug": "ghk-cu",
      "compoundAliases": [
        "Copper tripeptide",
        "GHK Cu",
        "Copper tripeptide-1",
        "Prezatide copper"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "GHK-Cu in Quebec",
      "boundedAnswer": "GHK-Cu in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries"
    },
    {
      "recordId": "pl-canada-province-ghk-cu-saskatchewan",
      "compound": "GHK-Cu",
      "compoundSlug": "ghk-cu",
      "compoundAliases": [
        "Copper tripeptide",
        "GHK Cu",
        "Copper tripeptide-1",
        "Prezatide copper"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "GHK-Cu in Saskatchewan",
      "boundedAnswer": "GHK-Cu in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries"
    },
    {
      "recordId": "pl-canada-province-semax-alberta",
      "compound": "Semax",
      "compoundSlug": "semax",
      "compoundAliases": [
        "ACTH(4-7)-PGP",
        "MEHFPGP",
        "Semax heptapeptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Semax in Alberta",
      "boundedAnswer": "Semax in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/semax",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries"
    },
    {
      "recordId": "pl-canada-province-semax-british-columbia",
      "compound": "Semax",
      "compoundSlug": "semax",
      "compoundAliases": [
        "ACTH(4-7)-PGP",
        "MEHFPGP",
        "Semax heptapeptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Semax in British Columbia",
      "boundedAnswer": "Semax in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/semax",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries"
    },
    {
      "recordId": "pl-canada-province-semax-manitoba",
      "compound": "Semax",
      "compoundSlug": "semax",
      "compoundAliases": [
        "ACTH(4-7)-PGP",
        "MEHFPGP",
        "Semax heptapeptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Semax in Manitoba",
      "boundedAnswer": "Semax in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/semax",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries"
    },
    {
      "recordId": "pl-canada-province-semax-new-brunswick",
      "compound": "Semax",
      "compoundSlug": "semax",
      "compoundAliases": [
        "ACTH(4-7)-PGP",
        "MEHFPGP",
        "Semax heptapeptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Semax in New Brunswick",
      "boundedAnswer": "Semax in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/semax",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries"
    },
    {
      "recordId": "pl-canada-province-semax-newfoundland-and-labrador",
      "compound": "Semax",
      "compoundSlug": "semax",
      "compoundAliases": [
        "ACTH(4-7)-PGP",
        "MEHFPGP",
        "Semax heptapeptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Semax in Newfoundland and Labrador",
      "boundedAnswer": "Semax in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/semax",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries"
    },
    {
      "recordId": "pl-canada-province-semax-nova-scotia",
      "compound": "Semax",
      "compoundSlug": "semax",
      "compoundAliases": [
        "ACTH(4-7)-PGP",
        "MEHFPGP",
        "Semax heptapeptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Semax in Nova Scotia",
      "boundedAnswer": "Semax in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/semax",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries"
    },
    {
      "recordId": "pl-canada-province-semax-ontario",
      "compound": "Semax",
      "compoundSlug": "semax",
      "compoundAliases": [
        "ACTH(4-7)-PGP",
        "MEHFPGP",
        "Semax heptapeptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Semax in Ontario",
      "boundedAnswer": "Semax in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/semax",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries"
    },
    {
      "recordId": "pl-canada-province-semax-prince-edward-island",
      "compound": "Semax",
      "compoundSlug": "semax",
      "compoundAliases": [
        "ACTH(4-7)-PGP",
        "MEHFPGP",
        "Semax heptapeptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Semax in Prince Edward Island",
      "boundedAnswer": "Semax in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/semax",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries"
    },
    {
      "recordId": "pl-canada-province-semax-quebec",
      "compound": "Semax",
      "compoundSlug": "semax",
      "compoundAliases": [
        "ACTH(4-7)-PGP",
        "MEHFPGP",
        "Semax heptapeptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Semax in Quebec",
      "boundedAnswer": "Semax in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/semax",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries"
    },
    {
      "recordId": "pl-canada-province-semax-saskatchewan",
      "compound": "Semax",
      "compoundSlug": "semax",
      "compoundAliases": [
        "ACTH(4-7)-PGP",
        "MEHFPGP",
        "Semax heptapeptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Semax in Saskatchewan",
      "boundedAnswer": "Semax in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/semax",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-ii-alberta",
      "compound": "Melanotan II",
      "compoundSlug": "melanotan-ii",
      "compoundAliases": [
        "MT-II",
        "MT2",
        "Melanotan 2"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Melanotan II in Alberta",
      "boundedAnswer": "Melanotan II in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-ii-british-columbia",
      "compound": "Melanotan II",
      "compoundSlug": "melanotan-ii",
      "compoundAliases": [
        "MT-II",
        "MT2",
        "Melanotan 2"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Melanotan II in British Columbia",
      "boundedAnswer": "Melanotan II in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-ii-manitoba",
      "compound": "Melanotan II",
      "compoundSlug": "melanotan-ii",
      "compoundAliases": [
        "MT-II",
        "MT2",
        "Melanotan 2"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Melanotan II in Manitoba",
      "boundedAnswer": "Melanotan II in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-ii-new-brunswick",
      "compound": "Melanotan II",
      "compoundSlug": "melanotan-ii",
      "compoundAliases": [
        "MT-II",
        "MT2",
        "Melanotan 2"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Melanotan II in New Brunswick",
      "boundedAnswer": "Melanotan II in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-ii-newfoundland-and-labrador",
      "compound": "Melanotan II",
      "compoundSlug": "melanotan-ii",
      "compoundAliases": [
        "MT-II",
        "MT2",
        "Melanotan 2"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Melanotan II in Newfoundland and Labrador",
      "boundedAnswer": "Melanotan II in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-ii-nova-scotia",
      "compound": "Melanotan II",
      "compoundSlug": "melanotan-ii",
      "compoundAliases": [
        "MT-II",
        "MT2",
        "Melanotan 2"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Melanotan II in Nova Scotia",
      "boundedAnswer": "Melanotan II in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-ii-ontario",
      "compound": "Melanotan II",
      "compoundSlug": "melanotan-ii",
      "compoundAliases": [
        "MT-II",
        "MT2",
        "Melanotan 2"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Melanotan II in Ontario",
      "boundedAnswer": "Melanotan II in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-ii-prince-edward-island",
      "compound": "Melanotan II",
      "compoundSlug": "melanotan-ii",
      "compoundAliases": [
        "MT-II",
        "MT2",
        "Melanotan 2"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Melanotan II in Prince Edward Island",
      "boundedAnswer": "Melanotan II in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-ii-quebec",
      "compound": "Melanotan II",
      "compoundSlug": "melanotan-ii",
      "compoundAliases": [
        "MT-II",
        "MT2",
        "Melanotan 2"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Melanotan II in Quebec",
      "boundedAnswer": "Melanotan II in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-ii-saskatchewan",
      "compound": "Melanotan II",
      "compoundSlug": "melanotan-ii",
      "compoundAliases": [
        "MT-II",
        "MT2",
        "Melanotan 2"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Melanotan II in Saskatchewan",
      "boundedAnswer": "Melanotan II in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries"
    },
    {
      "recordId": "pl-canada-province-mots-c-alberta",
      "compound": "MOTS-c",
      "compoundSlug": "mots-c",
      "compoundAliases": [
        "MOTS c",
        "Mitochondrial open reading frame peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "MOTS-c in Alberta",
      "boundedAnswer": "MOTS-c in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/mots-c",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries"
    },
    {
      "recordId": "pl-canada-province-mots-c-british-columbia",
      "compound": "MOTS-c",
      "compoundSlug": "mots-c",
      "compoundAliases": [
        "MOTS c",
        "Mitochondrial open reading frame peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "MOTS-c in British Columbia",
      "boundedAnswer": "MOTS-c in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/mots-c",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries"
    },
    {
      "recordId": "pl-canada-province-mots-c-manitoba",
      "compound": "MOTS-c",
      "compoundSlug": "mots-c",
      "compoundAliases": [
        "MOTS c",
        "Mitochondrial open reading frame peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "MOTS-c in Manitoba",
      "boundedAnswer": "MOTS-c in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/mots-c",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries"
    },
    {
      "recordId": "pl-canada-province-mots-c-new-brunswick",
      "compound": "MOTS-c",
      "compoundSlug": "mots-c",
      "compoundAliases": [
        "MOTS c",
        "Mitochondrial open reading frame peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "MOTS-c in New Brunswick",
      "boundedAnswer": "MOTS-c in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/mots-c",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries"
    },
    {
      "recordId": "pl-canada-province-mots-c-newfoundland-and-labrador",
      "compound": "MOTS-c",
      "compoundSlug": "mots-c",
      "compoundAliases": [
        "MOTS c",
        "Mitochondrial open reading frame peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "MOTS-c in Newfoundland and Labrador",
      "boundedAnswer": "MOTS-c in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/mots-c",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries"
    },
    {
      "recordId": "pl-canada-province-mots-c-nova-scotia",
      "compound": "MOTS-c",
      "compoundSlug": "mots-c",
      "compoundAliases": [
        "MOTS c",
        "Mitochondrial open reading frame peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "MOTS-c in Nova Scotia",
      "boundedAnswer": "MOTS-c in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/mots-c",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries"
    },
    {
      "recordId": "pl-canada-province-mots-c-ontario",
      "compound": "MOTS-c",
      "compoundSlug": "mots-c",
      "compoundAliases": [
        "MOTS c",
        "Mitochondrial open reading frame peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "MOTS-c in Ontario",
      "boundedAnswer": "MOTS-c in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/mots-c",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries"
    },
    {
      "recordId": "pl-canada-province-mots-c-prince-edward-island",
      "compound": "MOTS-c",
      "compoundSlug": "mots-c",
      "compoundAliases": [
        "MOTS c",
        "Mitochondrial open reading frame peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "MOTS-c in Prince Edward Island",
      "boundedAnswer": "MOTS-c in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/mots-c",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries"
    },
    {
      "recordId": "pl-canada-province-mots-c-quebec",
      "compound": "MOTS-c",
      "compoundSlug": "mots-c",
      "compoundAliases": [
        "MOTS c",
        "Mitochondrial open reading frame peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "MOTS-c in Quebec",
      "boundedAnswer": "MOTS-c in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/mots-c",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries"
    },
    {
      "recordId": "pl-canada-province-mots-c-saskatchewan",
      "compound": "MOTS-c",
      "compoundSlug": "mots-c",
      "compoundAliases": [
        "MOTS c",
        "Mitochondrial open reading frame peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "MOTS-c in Saskatchewan",
      "boundedAnswer": "MOTS-c in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/mots-c",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries"
    },
    {
      "recordId": "pl-canada-province-tesamorelin-alberta",
      "compound": "Tesamorelin",
      "compoundSlug": "tesamorelin",
      "compoundAliases": [
        "Egrifta",
        "TH9507"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-licensed medicine record",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Tesamorelin in Alberta",
      "boundedAnswer": "Tesamorelin in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin",
      "identitySourceLabel": "Check the FDA Purple Book product record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-tesamorelin-british-columbia",
      "compound": "Tesamorelin",
      "compoundSlug": "tesamorelin",
      "compoundAliases": [
        "Egrifta",
        "TH9507"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-licensed medicine record",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Tesamorelin in British Columbia",
      "boundedAnswer": "Tesamorelin in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin",
      "identitySourceLabel": "Check the FDA Purple Book product record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-tesamorelin-manitoba",
      "compound": "Tesamorelin",
      "compoundSlug": "tesamorelin",
      "compoundAliases": [
        "Egrifta",
        "TH9507"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-licensed medicine record",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Tesamorelin in Manitoba",
      "boundedAnswer": "Tesamorelin in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin",
      "identitySourceLabel": "Check the FDA Purple Book product record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-tesamorelin-new-brunswick",
      "compound": "Tesamorelin",
      "compoundSlug": "tesamorelin",
      "compoundAliases": [
        "Egrifta",
        "TH9507"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-licensed medicine record",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Tesamorelin in New Brunswick",
      "boundedAnswer": "Tesamorelin in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin",
      "identitySourceLabel": "Check the FDA Purple Book product record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-tesamorelin-newfoundland-and-labrador",
      "compound": "Tesamorelin",
      "compoundSlug": "tesamorelin",
      "compoundAliases": [
        "Egrifta",
        "TH9507"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-licensed medicine record",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Tesamorelin in Newfoundland and Labrador",
      "boundedAnswer": "Tesamorelin in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin",
      "identitySourceLabel": "Check the FDA Purple Book product record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-tesamorelin-nova-scotia",
      "compound": "Tesamorelin",
      "compoundSlug": "tesamorelin",
      "compoundAliases": [
        "Egrifta",
        "TH9507"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-licensed medicine record",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Tesamorelin in Nova Scotia",
      "boundedAnswer": "Tesamorelin in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin",
      "identitySourceLabel": "Check the FDA Purple Book product record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-tesamorelin-ontario",
      "compound": "Tesamorelin",
      "compoundSlug": "tesamorelin",
      "compoundAliases": [
        "Egrifta",
        "TH9507"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-licensed medicine record",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Tesamorelin in Ontario",
      "boundedAnswer": "Tesamorelin in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin",
      "identitySourceLabel": "Check the FDA Purple Book product record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-tesamorelin-prince-edward-island",
      "compound": "Tesamorelin",
      "compoundSlug": "tesamorelin",
      "compoundAliases": [
        "Egrifta",
        "TH9507"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-licensed medicine record",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Tesamorelin in Prince Edward Island",
      "boundedAnswer": "Tesamorelin in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin",
      "identitySourceLabel": "Check the FDA Purple Book product record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-tesamorelin-quebec",
      "compound": "Tesamorelin",
      "compoundSlug": "tesamorelin",
      "compoundAliases": [
        "Egrifta",
        "TH9507"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-licensed medicine record",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Tesamorelin in Quebec",
      "boundedAnswer": "Tesamorelin in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin",
      "identitySourceLabel": "Check the FDA Purple Book product record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-tesamorelin-saskatchewan",
      "compound": "Tesamorelin",
      "compoundSlug": "tesamorelin",
      "compoundAliases": [
        "Egrifta",
        "TH9507"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-licensed medicine record",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Tesamorelin in Saskatchewan",
      "boundedAnswer": "Tesamorelin in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin",
      "identitySourceLabel": "Check the FDA Purple Book product record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-aod-9604-alberta",
      "compound": "AOD-9604",
      "compoundSlug": "aod-9604",
      "compoundAliases": [
        "AOD 9604",
        "AOD9604",
        "Tyr-hGH 177-191"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "AOD-9604 in Alberta",
      "boundedAnswer": "AOD-9604 in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/aod-9604",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries"
    },
    {
      "recordId": "pl-canada-province-aod-9604-british-columbia",
      "compound": "AOD-9604",
      "compoundSlug": "aod-9604",
      "compoundAliases": [
        "AOD 9604",
        "AOD9604",
        "Tyr-hGH 177-191"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "AOD-9604 in British Columbia",
      "boundedAnswer": "AOD-9604 in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/aod-9604",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries"
    },
    {
      "recordId": "pl-canada-province-aod-9604-manitoba",
      "compound": "AOD-9604",
      "compoundSlug": "aod-9604",
      "compoundAliases": [
        "AOD 9604",
        "AOD9604",
        "Tyr-hGH 177-191"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "AOD-9604 in Manitoba",
      "boundedAnswer": "AOD-9604 in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/aod-9604",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries"
    },
    {
      "recordId": "pl-canada-province-aod-9604-new-brunswick",
      "compound": "AOD-9604",
      "compoundSlug": "aod-9604",
      "compoundAliases": [
        "AOD 9604",
        "AOD9604",
        "Tyr-hGH 177-191"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "AOD-9604 in New Brunswick",
      "boundedAnswer": "AOD-9604 in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/aod-9604",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries"
    },
    {
      "recordId": "pl-canada-province-aod-9604-newfoundland-and-labrador",
      "compound": "AOD-9604",
      "compoundSlug": "aod-9604",
      "compoundAliases": [
        "AOD 9604",
        "AOD9604",
        "Tyr-hGH 177-191"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "AOD-9604 in Newfoundland and Labrador",
      "boundedAnswer": "AOD-9604 in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/aod-9604",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries"
    },
    {
      "recordId": "pl-canada-province-aod-9604-nova-scotia",
      "compound": "AOD-9604",
      "compoundSlug": "aod-9604",
      "compoundAliases": [
        "AOD 9604",
        "AOD9604",
        "Tyr-hGH 177-191"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "AOD-9604 in Nova Scotia",
      "boundedAnswer": "AOD-9604 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/aod-9604",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries"
    },
    {
      "recordId": "pl-canada-province-aod-9604-ontario",
      "compound": "AOD-9604",
      "compoundSlug": "aod-9604",
      "compoundAliases": [
        "AOD 9604",
        "AOD9604",
        "Tyr-hGH 177-191"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "AOD-9604 in Ontario",
      "boundedAnswer": "AOD-9604 in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/aod-9604",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries"
    },
    {
      "recordId": "pl-canada-province-aod-9604-prince-edward-island",
      "compound": "AOD-9604",
      "compoundSlug": "aod-9604",
      "compoundAliases": [
        "AOD 9604",
        "AOD9604",
        "Tyr-hGH 177-191"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "AOD-9604 in Prince Edward Island",
      "boundedAnswer": "AOD-9604 in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/aod-9604",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries"
    },
    {
      "recordId": "pl-canada-province-aod-9604-quebec",
      "compound": "AOD-9604",
      "compoundSlug": "aod-9604",
      "compoundAliases": [
        "AOD 9604",
        "AOD9604",
        "Tyr-hGH 177-191"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "AOD-9604 in Quebec",
      "boundedAnswer": "AOD-9604 in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/aod-9604",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries"
    },
    {
      "recordId": "pl-canada-province-aod-9604-saskatchewan",
      "compound": "AOD-9604",
      "compoundSlug": "aod-9604",
      "compoundAliases": [
        "AOD 9604",
        "AOD9604",
        "Tyr-hGH 177-191"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "AOD-9604 in Saskatchewan",
      "boundedAnswer": "AOD-9604 in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/aod-9604",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries"
    },
    {
      "recordId": "pl-canada-province-ipamorelin-alberta",
      "compound": "Ipamorelin",
      "compoundSlug": "ipamorelin",
      "compoundAliases": [
        "NNC 26-0161",
        "growth hormone secretagogue"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Ipamorelin in Alberta",
      "boundedAnswer": "Ipamorelin in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-ipamorelin-british-columbia",
      "compound": "Ipamorelin",
      "compoundSlug": "ipamorelin",
      "compoundAliases": [
        "NNC 26-0161",
        "growth hormone secretagogue"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Ipamorelin in British Columbia",
      "boundedAnswer": "Ipamorelin in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-ipamorelin-manitoba",
      "compound": "Ipamorelin",
      "compoundSlug": "ipamorelin",
      "compoundAliases": [
        "NNC 26-0161",
        "growth hormone secretagogue"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Ipamorelin in Manitoba",
      "boundedAnswer": "Ipamorelin in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-ipamorelin-new-brunswick",
      "compound": "Ipamorelin",
      "compoundSlug": "ipamorelin",
      "compoundAliases": [
        "NNC 26-0161",
        "growth hormone secretagogue"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Ipamorelin in New Brunswick",
      "boundedAnswer": "Ipamorelin in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-ipamorelin-newfoundland-and-labrador",
      "compound": "Ipamorelin",
      "compoundSlug": "ipamorelin",
      "compoundAliases": [
        "NNC 26-0161",
        "growth hormone secretagogue"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Ipamorelin in Newfoundland and Labrador",
      "boundedAnswer": "Ipamorelin in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-ipamorelin-nova-scotia",
      "compound": "Ipamorelin",
      "compoundSlug": "ipamorelin",
      "compoundAliases": [
        "NNC 26-0161",
        "growth hormone secretagogue"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Ipamorelin in Nova Scotia",
      "boundedAnswer": "Ipamorelin in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-ipamorelin-ontario",
      "compound": "Ipamorelin",
      "compoundSlug": "ipamorelin",
      "compoundAliases": [
        "NNC 26-0161",
        "growth hormone secretagogue"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Ipamorelin in Ontario",
      "boundedAnswer": "Ipamorelin in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-ipamorelin-prince-edward-island",
      "compound": "Ipamorelin",
      "compoundSlug": "ipamorelin",
      "compoundAliases": [
        "NNC 26-0161",
        "growth hormone secretagogue"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Ipamorelin in Prince Edward Island",
      "boundedAnswer": "Ipamorelin in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-ipamorelin-quebec",
      "compound": "Ipamorelin",
      "compoundSlug": "ipamorelin",
      "compoundAliases": [
        "NNC 26-0161",
        "growth hormone secretagogue"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Ipamorelin in Quebec",
      "boundedAnswer": "Ipamorelin in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-ipamorelin-saskatchewan",
      "compound": "Ipamorelin",
      "compoundSlug": "ipamorelin",
      "compoundAliases": [
        "NNC 26-0161",
        "growth hormone secretagogue"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Ipamorelin in Saskatchewan",
      "boundedAnswer": "Ipamorelin in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries"
    },
    {
      "recordId": "pl-canada-province-selank-alberta",
      "compound": "Selank",
      "compoundSlug": "selank",
      "compoundAliases": [
        "TP-7",
        "selank acetate"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Selank in Alberta",
      "boundedAnswer": "Selank in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/selank",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries"
    },
    {
      "recordId": "pl-canada-province-selank-british-columbia",
      "compound": "Selank",
      "compoundSlug": "selank",
      "compoundAliases": [
        "TP-7",
        "selank acetate"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Selank in British Columbia",
      "boundedAnswer": "Selank in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/selank",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries"
    },
    {
      "recordId": "pl-canada-province-selank-manitoba",
      "compound": "Selank",
      "compoundSlug": "selank",
      "compoundAliases": [
        "TP-7",
        "selank acetate"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Selank in Manitoba",
      "boundedAnswer": "Selank in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/selank",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries"
    },
    {
      "recordId": "pl-canada-province-selank-new-brunswick",
      "compound": "Selank",
      "compoundSlug": "selank",
      "compoundAliases": [
        "TP-7",
        "selank acetate"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Selank in New Brunswick",
      "boundedAnswer": "Selank in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/selank",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries"
    },
    {
      "recordId": "pl-canada-province-selank-newfoundland-and-labrador",
      "compound": "Selank",
      "compoundSlug": "selank",
      "compoundAliases": [
        "TP-7",
        "selank acetate"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Selank in Newfoundland and Labrador",
      "boundedAnswer": "Selank in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/selank",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries"
    },
    {
      "recordId": "pl-canada-province-selank-nova-scotia",
      "compound": "Selank",
      "compoundSlug": "selank",
      "compoundAliases": [
        "TP-7",
        "selank acetate"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Selank in Nova Scotia",
      "boundedAnswer": "Selank in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/selank",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries"
    },
    {
      "recordId": "pl-canada-province-selank-ontario",
      "compound": "Selank",
      "compoundSlug": "selank",
      "compoundAliases": [
        "TP-7",
        "selank acetate"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Selank in Ontario",
      "boundedAnswer": "Selank in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/selank",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries"
    },
    {
      "recordId": "pl-canada-province-selank-prince-edward-island",
      "compound": "Selank",
      "compoundSlug": "selank",
      "compoundAliases": [
        "TP-7",
        "selank acetate"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Selank in Prince Edward Island",
      "boundedAnswer": "Selank in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/selank",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries"
    },
    {
      "recordId": "pl-canada-province-selank-quebec",
      "compound": "Selank",
      "compoundSlug": "selank",
      "compoundAliases": [
        "TP-7",
        "selank acetate"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Selank in Quebec",
      "boundedAnswer": "Selank in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/selank",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries"
    },
    {
      "recordId": "pl-canada-province-selank-saskatchewan",
      "compound": "Selank",
      "compoundSlug": "selank",
      "compoundAliases": [
        "TP-7",
        "selank acetate"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Selank in Saskatchewan",
      "boundedAnswer": "Selank in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/selank",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries"
    },
    {
      "recordId": "pl-canada-province-pt-141-alberta",
      "compound": "PT-141 / Bremelanotide",
      "compoundSlug": "pt-141",
      "compoundAliases": [
        "PT 141",
        "Bremelanotide",
        "Vyleesi"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-approved medicine record",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "PT-141 / Bremelanotide in Alberta",
      "boundedAnswer": "PT-141 / Bremelanotide in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/pt-141",
      "identitySourceLabel": "Read the current DailyMed drug label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries"
    },
    {
      "recordId": "pl-canada-province-pt-141-british-columbia",
      "compound": "PT-141 / Bremelanotide",
      "compoundSlug": "pt-141",
      "compoundAliases": [
        "PT 141",
        "Bremelanotide",
        "Vyleesi"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-approved medicine record",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "PT-141 / Bremelanotide in British Columbia",
      "boundedAnswer": "PT-141 / Bremelanotide in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/pt-141",
      "identitySourceLabel": "Read the current DailyMed drug label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries"
    },
    {
      "recordId": "pl-canada-province-pt-141-manitoba",
      "compound": "PT-141 / Bremelanotide",
      "compoundSlug": "pt-141",
      "compoundAliases": [
        "PT 141",
        "Bremelanotide",
        "Vyleesi"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-approved medicine record",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "PT-141 / Bremelanotide in Manitoba",
      "boundedAnswer": "PT-141 / Bremelanotide in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/pt-141",
      "identitySourceLabel": "Read the current DailyMed drug label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries"
    },
    {
      "recordId": "pl-canada-province-pt-141-new-brunswick",
      "compound": "PT-141 / Bremelanotide",
      "compoundSlug": "pt-141",
      "compoundAliases": [
        "PT 141",
        "Bremelanotide",
        "Vyleesi"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-approved medicine record",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "PT-141 / Bremelanotide in New Brunswick",
      "boundedAnswer": "PT-141 / Bremelanotide in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/pt-141",
      "identitySourceLabel": "Read the current DailyMed drug label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries"
    },
    {
      "recordId": "pl-canada-province-pt-141-newfoundland-and-labrador",
      "compound": "PT-141 / Bremelanotide",
      "compoundSlug": "pt-141",
      "compoundAliases": [
        "PT 141",
        "Bremelanotide",
        "Vyleesi"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-approved medicine record",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "PT-141 / Bremelanotide in Newfoundland and Labrador",
      "boundedAnswer": "PT-141 / Bremelanotide in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/pt-141",
      "identitySourceLabel": "Read the current DailyMed drug label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries"
    },
    {
      "recordId": "pl-canada-province-pt-141-nova-scotia",
      "compound": "PT-141 / Bremelanotide",
      "compoundSlug": "pt-141",
      "compoundAliases": [
        "PT 141",
        "Bremelanotide",
        "Vyleesi"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-approved medicine record",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "PT-141 / Bremelanotide in Nova Scotia",
      "boundedAnswer": "PT-141 / Bremelanotide in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/pt-141",
      "identitySourceLabel": "Read the current DailyMed drug label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries"
    },
    {
      "recordId": "pl-canada-province-pt-141-ontario",
      "compound": "PT-141 / Bremelanotide",
      "compoundSlug": "pt-141",
      "compoundAliases": [
        "PT 141",
        "Bremelanotide",
        "Vyleesi"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-approved medicine record",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "PT-141 / Bremelanotide in Ontario",
      "boundedAnswer": "PT-141 / Bremelanotide in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/pt-141",
      "identitySourceLabel": "Read the current DailyMed drug label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries"
    },
    {
      "recordId": "pl-canada-province-pt-141-prince-edward-island",
      "compound": "PT-141 / Bremelanotide",
      "compoundSlug": "pt-141",
      "compoundAliases": [
        "PT 141",
        "Bremelanotide",
        "Vyleesi"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-approved medicine record",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "PT-141 / Bremelanotide in Prince Edward Island",
      "boundedAnswer": "PT-141 / Bremelanotide in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/pt-141",
      "identitySourceLabel": "Read the current DailyMed drug label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries"
    },
    {
      "recordId": "pl-canada-province-pt-141-quebec",
      "compound": "PT-141 / Bremelanotide",
      "compoundSlug": "pt-141",
      "compoundAliases": [
        "PT 141",
        "Bremelanotide",
        "Vyleesi"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-approved medicine record",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "PT-141 / Bremelanotide in Quebec",
      "boundedAnswer": "PT-141 / Bremelanotide in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/pt-141",
      "identitySourceLabel": "Read the current DailyMed drug label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries"
    },
    {
      "recordId": "pl-canada-province-pt-141-saskatchewan",
      "compound": "PT-141 / Bremelanotide",
      "compoundSlug": "pt-141",
      "compoundAliases": [
        "PT 141",
        "Bremelanotide",
        "Vyleesi"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a separate FDA-approved medicine record",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "PT-141 / Bremelanotide in Saskatchewan",
      "boundedAnswer": "PT-141 / Bremelanotide in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/pt-141",
      "identitySourceLabel": "Read the current DailyMed drug label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-no-dac-alberta",
      "compound": "CJC-1295 no DAC",
      "compoundSlug": "cjc-1295-no-dac",
      "compoundAliases": [
        "Modified GRF 1-29",
        "Mod GRF 1-29",
        "CJC 1295 without DAC"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "CJC-1295 no DAC in Alberta",
      "boundedAnswer": "CJC-1295 no DAC in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-no-dac-british-columbia",
      "compound": "CJC-1295 no DAC",
      "compoundSlug": "cjc-1295-no-dac",
      "compoundAliases": [
        "Modified GRF 1-29",
        "Mod GRF 1-29",
        "CJC 1295 without DAC"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "CJC-1295 no DAC in British Columbia",
      "boundedAnswer": "CJC-1295 no DAC in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-no-dac-manitoba",
      "compound": "CJC-1295 no DAC",
      "compoundSlug": "cjc-1295-no-dac",
      "compoundAliases": [
        "Modified GRF 1-29",
        "Mod GRF 1-29",
        "CJC 1295 without DAC"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "CJC-1295 no DAC in Manitoba",
      "boundedAnswer": "CJC-1295 no DAC in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-no-dac-new-brunswick",
      "compound": "CJC-1295 no DAC",
      "compoundSlug": "cjc-1295-no-dac",
      "compoundAliases": [
        "Modified GRF 1-29",
        "Mod GRF 1-29",
        "CJC 1295 without DAC"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "CJC-1295 no DAC in New Brunswick",
      "boundedAnswer": "CJC-1295 no DAC in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-no-dac-newfoundland-and-labrador",
      "compound": "CJC-1295 no DAC",
      "compoundSlug": "cjc-1295-no-dac",
      "compoundAliases": [
        "Modified GRF 1-29",
        "Mod GRF 1-29",
        "CJC 1295 without DAC"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "CJC-1295 no DAC in Newfoundland and Labrador",
      "boundedAnswer": "CJC-1295 no DAC in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-no-dac-nova-scotia",
      "compound": "CJC-1295 no DAC",
      "compoundSlug": "cjc-1295-no-dac",
      "compoundAliases": [
        "Modified GRF 1-29",
        "Mod GRF 1-29",
        "CJC 1295 without DAC"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "CJC-1295 no DAC in Nova Scotia",
      "boundedAnswer": "CJC-1295 no DAC in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-no-dac-ontario",
      "compound": "CJC-1295 no DAC",
      "compoundSlug": "cjc-1295-no-dac",
      "compoundAliases": [
        "Modified GRF 1-29",
        "Mod GRF 1-29",
        "CJC 1295 without DAC"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "CJC-1295 no DAC in Ontario",
      "boundedAnswer": "CJC-1295 no DAC in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-no-dac-prince-edward-island",
      "compound": "CJC-1295 no DAC",
      "compoundSlug": "cjc-1295-no-dac",
      "compoundAliases": [
        "Modified GRF 1-29",
        "Mod GRF 1-29",
        "CJC 1295 without DAC"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "CJC-1295 no DAC in Prince Edward Island",
      "boundedAnswer": "CJC-1295 no DAC in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-no-dac-quebec",
      "compound": "CJC-1295 no DAC",
      "compoundSlug": "cjc-1295-no-dac",
      "compoundAliases": [
        "Modified GRF 1-29",
        "Mod GRF 1-29",
        "CJC 1295 without DAC"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "CJC-1295 no DAC in Quebec",
      "boundedAnswer": "CJC-1295 no DAC in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-no-dac-saskatchewan",
      "compound": "CJC-1295 no DAC",
      "compoundSlug": "cjc-1295-no-dac",
      "compoundAliases": [
        "Modified GRF 1-29",
        "Mod GRF 1-29",
        "CJC 1295 without DAC"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "CJC-1295 no DAC in Saskatchewan",
      "boundedAnswer": "CJC-1295 no DAC in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-dac-alberta",
      "compound": "CJC-1295 DAC",
      "compoundSlug": "cjc-1295-dac",
      "compoundAliases": [
        "CJC-1295 with DAC",
        "CJC 1295 DAC",
        "DAC:GRF"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "CJC-1295 DAC in Alberta",
      "boundedAnswer": "CJC-1295 DAC in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-dac-british-columbia",
      "compound": "CJC-1295 DAC",
      "compoundSlug": "cjc-1295-dac",
      "compoundAliases": [
        "CJC-1295 with DAC",
        "CJC 1295 DAC",
        "DAC:GRF"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "CJC-1295 DAC in British Columbia",
      "boundedAnswer": "CJC-1295 DAC in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-dac-manitoba",
      "compound": "CJC-1295 DAC",
      "compoundSlug": "cjc-1295-dac",
      "compoundAliases": [
        "CJC-1295 with DAC",
        "CJC 1295 DAC",
        "DAC:GRF"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "CJC-1295 DAC in Manitoba",
      "boundedAnswer": "CJC-1295 DAC in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-dac-new-brunswick",
      "compound": "CJC-1295 DAC",
      "compoundSlug": "cjc-1295-dac",
      "compoundAliases": [
        "CJC-1295 with DAC",
        "CJC 1295 DAC",
        "DAC:GRF"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "CJC-1295 DAC in New Brunswick",
      "boundedAnswer": "CJC-1295 DAC in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-dac-newfoundland-and-labrador",
      "compound": "CJC-1295 DAC",
      "compoundSlug": "cjc-1295-dac",
      "compoundAliases": [
        "CJC-1295 with DAC",
        "CJC 1295 DAC",
        "DAC:GRF"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "CJC-1295 DAC in Newfoundland and Labrador",
      "boundedAnswer": "CJC-1295 DAC in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-dac-nova-scotia",
      "compound": "CJC-1295 DAC",
      "compoundSlug": "cjc-1295-dac",
      "compoundAliases": [
        "CJC-1295 with DAC",
        "CJC 1295 DAC",
        "DAC:GRF"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "CJC-1295 DAC in Nova Scotia",
      "boundedAnswer": "CJC-1295 DAC in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-dac-ontario",
      "compound": "CJC-1295 DAC",
      "compoundSlug": "cjc-1295-dac",
      "compoundAliases": [
        "CJC-1295 with DAC",
        "CJC 1295 DAC",
        "DAC:GRF"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "CJC-1295 DAC in Ontario",
      "boundedAnswer": "CJC-1295 DAC in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-dac-prince-edward-island",
      "compound": "CJC-1295 DAC",
      "compoundSlug": "cjc-1295-dac",
      "compoundAliases": [
        "CJC-1295 with DAC",
        "CJC 1295 DAC",
        "DAC:GRF"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "CJC-1295 DAC in Prince Edward Island",
      "boundedAnswer": "CJC-1295 DAC in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-dac-quebec",
      "compound": "CJC-1295 DAC",
      "compoundSlug": "cjc-1295-dac",
      "compoundAliases": [
        "CJC-1295 with DAC",
        "CJC 1295 DAC",
        "DAC:GRF"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "CJC-1295 DAC in Quebec",
      "boundedAnswer": "CJC-1295 DAC in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries"
    },
    {
      "recordId": "pl-canada-province-cjc-1295-dac-saskatchewan",
      "compound": "CJC-1295 DAC",
      "compoundSlug": "cjc-1295-dac",
      "compoundAliases": [
        "CJC-1295 with DAC",
        "CJC 1295 DAC",
        "DAC:GRF"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "CJC-1295 DAC in Saskatchewan",
      "boundedAnswer": "CJC-1295 DAC in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries"
    },
    {
      "recordId": "pl-canada-province-retatrutide-alberta",
      "compound": "Retatrutide",
      "compoundSlug": "retatrutide",
      "compoundAliases": [
        "LY3437943",
        "triple agonist",
        "reta",
        "reta peptide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Retatrutide in Alberta",
      "boundedAnswer": "Retatrutide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide",
      "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries"
    },
    {
      "recordId": "pl-canada-province-retatrutide-british-columbia",
      "compound": "Retatrutide",
      "compoundSlug": "retatrutide",
      "compoundAliases": [
        "LY3437943",
        "triple agonist",
        "reta",
        "reta peptide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Retatrutide in British Columbia",
      "boundedAnswer": "Retatrutide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide",
      "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries"
    },
    {
      "recordId": "pl-canada-province-retatrutide-manitoba",
      "compound": "Retatrutide",
      "compoundSlug": "retatrutide",
      "compoundAliases": [
        "LY3437943",
        "triple agonist",
        "reta",
        "reta peptide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Retatrutide in Manitoba",
      "boundedAnswer": "Retatrutide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide",
      "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries"
    },
    {
      "recordId": "pl-canada-province-retatrutide-new-brunswick",
      "compound": "Retatrutide",
      "compoundSlug": "retatrutide",
      "compoundAliases": [
        "LY3437943",
        "triple agonist",
        "reta",
        "reta peptide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Retatrutide in New Brunswick",
      "boundedAnswer": "Retatrutide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide",
      "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries"
    },
    {
      "recordId": "pl-canada-province-retatrutide-newfoundland-and-labrador",
      "compound": "Retatrutide",
      "compoundSlug": "retatrutide",
      "compoundAliases": [
        "LY3437943",
        "triple agonist",
        "reta",
        "reta peptide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Retatrutide in Newfoundland and Labrador",
      "boundedAnswer": "Retatrutide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide",
      "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries"
    },
    {
      "recordId": "pl-canada-province-retatrutide-nova-scotia",
      "compound": "Retatrutide",
      "compoundSlug": "retatrutide",
      "compoundAliases": [
        "LY3437943",
        "triple agonist",
        "reta",
        "reta peptide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Retatrutide in Nova Scotia",
      "boundedAnswer": "Retatrutide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide",
      "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries"
    },
    {
      "recordId": "pl-canada-province-retatrutide-ontario",
      "compound": "Retatrutide",
      "compoundSlug": "retatrutide",
      "compoundAliases": [
        "LY3437943",
        "triple agonist",
        "reta",
        "reta peptide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Retatrutide in Ontario",
      "boundedAnswer": "Retatrutide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide",
      "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries"
    },
    {
      "recordId": "pl-canada-province-retatrutide-prince-edward-island",
      "compound": "Retatrutide",
      "compoundSlug": "retatrutide",
      "compoundAliases": [
        "LY3437943",
        "triple agonist",
        "reta",
        "reta peptide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Retatrutide in Prince Edward Island",
      "boundedAnswer": "Retatrutide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide",
      "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries"
    },
    {
      "recordId": "pl-canada-province-retatrutide-quebec",
      "compound": "Retatrutide",
      "compoundSlug": "retatrutide",
      "compoundAliases": [
        "LY3437943",
        "triple agonist",
        "reta",
        "reta peptide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Retatrutide in Quebec",
      "boundedAnswer": "Retatrutide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide",
      "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries"
    },
    {
      "recordId": "pl-canada-province-retatrutide-saskatchewan",
      "compound": "Retatrutide",
      "compoundSlug": "retatrutide",
      "compoundAliases": [
        "LY3437943",
        "triple agonist",
        "reta",
        "reta peptide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Retatrutide in Saskatchewan",
      "boundedAnswer": "Retatrutide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide",
      "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries"
    },
    {
      "recordId": "pl-canada-province-mazdutide-alberta",
      "compound": "Mazdutide",
      "compoundSlug": "mazdutide",
      "compoundAliases": [
        "IBI362",
        "LY3305677",
        "GLP-1/glucagon dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Mazdutide in Alberta",
      "boundedAnswer": "Mazdutide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide",
      "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries"
    },
    {
      "recordId": "pl-canada-province-mazdutide-british-columbia",
      "compound": "Mazdutide",
      "compoundSlug": "mazdutide",
      "compoundAliases": [
        "IBI362",
        "LY3305677",
        "GLP-1/glucagon dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Mazdutide in British Columbia",
      "boundedAnswer": "Mazdutide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide",
      "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries"
    },
    {
      "recordId": "pl-canada-province-mazdutide-manitoba",
      "compound": "Mazdutide",
      "compoundSlug": "mazdutide",
      "compoundAliases": [
        "IBI362",
        "LY3305677",
        "GLP-1/glucagon dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Mazdutide in Manitoba",
      "boundedAnswer": "Mazdutide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide",
      "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries"
    },
    {
      "recordId": "pl-canada-province-mazdutide-new-brunswick",
      "compound": "Mazdutide",
      "compoundSlug": "mazdutide",
      "compoundAliases": [
        "IBI362",
        "LY3305677",
        "GLP-1/glucagon dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Mazdutide in New Brunswick",
      "boundedAnswer": "Mazdutide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide",
      "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries"
    },
    {
      "recordId": "pl-canada-province-mazdutide-newfoundland-and-labrador",
      "compound": "Mazdutide",
      "compoundSlug": "mazdutide",
      "compoundAliases": [
        "IBI362",
        "LY3305677",
        "GLP-1/glucagon dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Mazdutide in Newfoundland and Labrador",
      "boundedAnswer": "Mazdutide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide",
      "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries"
    },
    {
      "recordId": "pl-canada-province-mazdutide-nova-scotia",
      "compound": "Mazdutide",
      "compoundSlug": "mazdutide",
      "compoundAliases": [
        "IBI362",
        "LY3305677",
        "GLP-1/glucagon dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Mazdutide in Nova Scotia",
      "boundedAnswer": "Mazdutide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide",
      "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries"
    },
    {
      "recordId": "pl-canada-province-mazdutide-ontario",
      "compound": "Mazdutide",
      "compoundSlug": "mazdutide",
      "compoundAliases": [
        "IBI362",
        "LY3305677",
        "GLP-1/glucagon dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Mazdutide in Ontario",
      "boundedAnswer": "Mazdutide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide",
      "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries"
    },
    {
      "recordId": "pl-canada-province-mazdutide-prince-edward-island",
      "compound": "Mazdutide",
      "compoundSlug": "mazdutide",
      "compoundAliases": [
        "IBI362",
        "LY3305677",
        "GLP-1/glucagon dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Mazdutide in Prince Edward Island",
      "boundedAnswer": "Mazdutide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide",
      "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries"
    },
    {
      "recordId": "pl-canada-province-mazdutide-quebec",
      "compound": "Mazdutide",
      "compoundSlug": "mazdutide",
      "compoundAliases": [
        "IBI362",
        "LY3305677",
        "GLP-1/glucagon dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Mazdutide in Quebec",
      "boundedAnswer": "Mazdutide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide",
      "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries"
    },
    {
      "recordId": "pl-canada-province-mazdutide-saskatchewan",
      "compound": "Mazdutide",
      "compoundSlug": "mazdutide",
      "compoundAliases": [
        "IBI362",
        "LY3305677",
        "GLP-1/glucagon dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Mazdutide in Saskatchewan",
      "boundedAnswer": "Mazdutide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide",
      "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries"
    },
    {
      "recordId": "pl-canada-province-ecnoglutide-alberta",
      "compound": "Ecnoglutide",
      "compoundSlug": "ecnoglutide",
      "compoundAliases": [
        "XW003",
        "Sciwind ecnoglutide",
        "cAMP-biased GLP-1 receptor agonist",
        "埃诺格鲁肽"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active development program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Ecnoglutide in Alberta",
      "boundedAnswer": "Ecnoglutide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide",
      "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries"
    },
    {
      "recordId": "pl-canada-province-ecnoglutide-british-columbia",
      "compound": "Ecnoglutide",
      "compoundSlug": "ecnoglutide",
      "compoundAliases": [
        "XW003",
        "Sciwind ecnoglutide",
        "cAMP-biased GLP-1 receptor agonist",
        "埃诺格鲁肽"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active development program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Ecnoglutide in British Columbia",
      "boundedAnswer": "Ecnoglutide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide",
      "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries"
    },
    {
      "recordId": "pl-canada-province-ecnoglutide-manitoba",
      "compound": "Ecnoglutide",
      "compoundSlug": "ecnoglutide",
      "compoundAliases": [
        "XW003",
        "Sciwind ecnoglutide",
        "cAMP-biased GLP-1 receptor agonist",
        "埃诺格鲁肽"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active development program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Ecnoglutide in Manitoba",
      "boundedAnswer": "Ecnoglutide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide",
      "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries"
    },
    {
      "recordId": "pl-canada-province-ecnoglutide-new-brunswick",
      "compound": "Ecnoglutide",
      "compoundSlug": "ecnoglutide",
      "compoundAliases": [
        "XW003",
        "Sciwind ecnoglutide",
        "cAMP-biased GLP-1 receptor agonist",
        "埃诺格鲁肽"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active development program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Ecnoglutide in New Brunswick",
      "boundedAnswer": "Ecnoglutide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide",
      "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries"
    },
    {
      "recordId": "pl-canada-province-ecnoglutide-newfoundland-and-labrador",
      "compound": "Ecnoglutide",
      "compoundSlug": "ecnoglutide",
      "compoundAliases": [
        "XW003",
        "Sciwind ecnoglutide",
        "cAMP-biased GLP-1 receptor agonist",
        "埃诺格鲁肽"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active development program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Ecnoglutide in Newfoundland and Labrador",
      "boundedAnswer": "Ecnoglutide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide",
      "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries"
    },
    {
      "recordId": "pl-canada-province-ecnoglutide-nova-scotia",
      "compound": "Ecnoglutide",
      "compoundSlug": "ecnoglutide",
      "compoundAliases": [
        "XW003",
        "Sciwind ecnoglutide",
        "cAMP-biased GLP-1 receptor agonist",
        "埃诺格鲁肽"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active development program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Ecnoglutide in Nova Scotia",
      "boundedAnswer": "Ecnoglutide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide",
      "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries"
    },
    {
      "recordId": "pl-canada-province-ecnoglutide-ontario",
      "compound": "Ecnoglutide",
      "compoundSlug": "ecnoglutide",
      "compoundAliases": [
        "XW003",
        "Sciwind ecnoglutide",
        "cAMP-biased GLP-1 receptor agonist",
        "埃诺格鲁肽"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active development program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Ecnoglutide in Ontario",
      "boundedAnswer": "Ecnoglutide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide",
      "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries"
    },
    {
      "recordId": "pl-canada-province-ecnoglutide-prince-edward-island",
      "compound": "Ecnoglutide",
      "compoundSlug": "ecnoglutide",
      "compoundAliases": [
        "XW003",
        "Sciwind ecnoglutide",
        "cAMP-biased GLP-1 receptor agonist",
        "埃诺格鲁肽"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active development program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Ecnoglutide in Prince Edward Island",
      "boundedAnswer": "Ecnoglutide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide",
      "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries"
    },
    {
      "recordId": "pl-canada-province-ecnoglutide-quebec",
      "compound": "Ecnoglutide",
      "compoundSlug": "ecnoglutide",
      "compoundAliases": [
        "XW003",
        "Sciwind ecnoglutide",
        "cAMP-biased GLP-1 receptor agonist",
        "埃诺格鲁肽"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active development program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Ecnoglutide in Quebec",
      "boundedAnswer": "Ecnoglutide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide",
      "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries"
    },
    {
      "recordId": "pl-canada-province-ecnoglutide-saskatchewan",
      "compound": "Ecnoglutide",
      "compoundSlug": "ecnoglutide",
      "compoundAliases": [
        "XW003",
        "Sciwind ecnoglutide",
        "cAMP-biased GLP-1 receptor agonist",
        "埃诺格鲁肽"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "China-approved medicine and active development program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Ecnoglutide in Saskatchewan",
      "boundedAnswer": "Ecnoglutide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide",
      "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries"
    },
    {
      "recordId": "pl-canada-province-enicepatide-alberta",
      "compound": "Enicepatide",
      "compoundSlug": "enicepatide",
      "compoundAliases": [
        "CT-388",
        "RO7795068",
        "RG6640"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Enicepatide in Alberta",
      "boundedAnswer": "Enicepatide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide",
      "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries"
    },
    {
      "recordId": "pl-canada-province-enicepatide-british-columbia",
      "compound": "Enicepatide",
      "compoundSlug": "enicepatide",
      "compoundAliases": [
        "CT-388",
        "RO7795068",
        "RG6640"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Enicepatide in British Columbia",
      "boundedAnswer": "Enicepatide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide",
      "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries"
    },
    {
      "recordId": "pl-canada-province-enicepatide-manitoba",
      "compound": "Enicepatide",
      "compoundSlug": "enicepatide",
      "compoundAliases": [
        "CT-388",
        "RO7795068",
        "RG6640"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Enicepatide in Manitoba",
      "boundedAnswer": "Enicepatide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide",
      "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries"
    },
    {
      "recordId": "pl-canada-province-enicepatide-new-brunswick",
      "compound": "Enicepatide",
      "compoundSlug": "enicepatide",
      "compoundAliases": [
        "CT-388",
        "RO7795068",
        "RG6640"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Enicepatide in New Brunswick",
      "boundedAnswer": "Enicepatide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide",
      "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries"
    },
    {
      "recordId": "pl-canada-province-enicepatide-newfoundland-and-labrador",
      "compound": "Enicepatide",
      "compoundSlug": "enicepatide",
      "compoundAliases": [
        "CT-388",
        "RO7795068",
        "RG6640"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Enicepatide in Newfoundland and Labrador",
      "boundedAnswer": "Enicepatide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide",
      "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries"
    },
    {
      "recordId": "pl-canada-province-enicepatide-nova-scotia",
      "compound": "Enicepatide",
      "compoundSlug": "enicepatide",
      "compoundAliases": [
        "CT-388",
        "RO7795068",
        "RG6640"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Enicepatide in Nova Scotia",
      "boundedAnswer": "Enicepatide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide",
      "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries"
    },
    {
      "recordId": "pl-canada-province-enicepatide-ontario",
      "compound": "Enicepatide",
      "compoundSlug": "enicepatide",
      "compoundAliases": [
        "CT-388",
        "RO7795068",
        "RG6640"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Enicepatide in Ontario",
      "boundedAnswer": "Enicepatide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide",
      "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries"
    },
    {
      "recordId": "pl-canada-province-enicepatide-prince-edward-island",
      "compound": "Enicepatide",
      "compoundSlug": "enicepatide",
      "compoundAliases": [
        "CT-388",
        "RO7795068",
        "RG6640"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Enicepatide in Prince Edward Island",
      "boundedAnswer": "Enicepatide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide",
      "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries"
    },
    {
      "recordId": "pl-canada-province-enicepatide-quebec",
      "compound": "Enicepatide",
      "compoundSlug": "enicepatide",
      "compoundAliases": [
        "CT-388",
        "RO7795068",
        "RG6640"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Enicepatide in Quebec",
      "boundedAnswer": "Enicepatide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide",
      "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries"
    },
    {
      "recordId": "pl-canada-province-enicepatide-saskatchewan",
      "compound": "Enicepatide",
      "compoundSlug": "enicepatide",
      "compoundAliases": [
        "CT-388",
        "RO7795068",
        "RG6640"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Enicepatide in Saskatchewan",
      "boundedAnswer": "Enicepatide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide",
      "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries"
    },
    {
      "recordId": "pl-canada-province-eloralintide-alberta",
      "compound": "Eloralintide",
      "compoundSlug": "eloralintide",
      "compoundAliases": [
        "LY3841136",
        "eloralintide peptide",
        "selective amylin receptor agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Eloralintide in Alberta",
      "boundedAnswer": "Eloralintide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide",
      "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries"
    },
    {
      "recordId": "pl-canada-province-eloralintide-british-columbia",
      "compound": "Eloralintide",
      "compoundSlug": "eloralintide",
      "compoundAliases": [
        "LY3841136",
        "eloralintide peptide",
        "selective amylin receptor agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Eloralintide in British Columbia",
      "boundedAnswer": "Eloralintide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide",
      "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries"
    },
    {
      "recordId": "pl-canada-province-eloralintide-manitoba",
      "compound": "Eloralintide",
      "compoundSlug": "eloralintide",
      "compoundAliases": [
        "LY3841136",
        "eloralintide peptide",
        "selective amylin receptor agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Eloralintide in Manitoba",
      "boundedAnswer": "Eloralintide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide",
      "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries"
    },
    {
      "recordId": "pl-canada-province-eloralintide-new-brunswick",
      "compound": "Eloralintide",
      "compoundSlug": "eloralintide",
      "compoundAliases": [
        "LY3841136",
        "eloralintide peptide",
        "selective amylin receptor agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Eloralintide in New Brunswick",
      "boundedAnswer": "Eloralintide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide",
      "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries"
    },
    {
      "recordId": "pl-canada-province-eloralintide-newfoundland-and-labrador",
      "compound": "Eloralintide",
      "compoundSlug": "eloralintide",
      "compoundAliases": [
        "LY3841136",
        "eloralintide peptide",
        "selective amylin receptor agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Eloralintide in Newfoundland and Labrador",
      "boundedAnswer": "Eloralintide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide",
      "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries"
    },
    {
      "recordId": "pl-canada-province-eloralintide-nova-scotia",
      "compound": "Eloralintide",
      "compoundSlug": "eloralintide",
      "compoundAliases": [
        "LY3841136",
        "eloralintide peptide",
        "selective amylin receptor agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Eloralintide in Nova Scotia",
      "boundedAnswer": "Eloralintide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide",
      "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries"
    },
    {
      "recordId": "pl-canada-province-eloralintide-ontario",
      "compound": "Eloralintide",
      "compoundSlug": "eloralintide",
      "compoundAliases": [
        "LY3841136",
        "eloralintide peptide",
        "selective amylin receptor agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Eloralintide in Ontario",
      "boundedAnswer": "Eloralintide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide",
      "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries"
    },
    {
      "recordId": "pl-canada-province-eloralintide-prince-edward-island",
      "compound": "Eloralintide",
      "compoundSlug": "eloralintide",
      "compoundAliases": [
        "LY3841136",
        "eloralintide peptide",
        "selective amylin receptor agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Eloralintide in Prince Edward Island",
      "boundedAnswer": "Eloralintide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide",
      "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries"
    },
    {
      "recordId": "pl-canada-province-eloralintide-quebec",
      "compound": "Eloralintide",
      "compoundSlug": "eloralintide",
      "compoundAliases": [
        "LY3841136",
        "eloralintide peptide",
        "selective amylin receptor agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Eloralintide in Quebec",
      "boundedAnswer": "Eloralintide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide",
      "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries"
    },
    {
      "recordId": "pl-canada-province-eloralintide-saskatchewan",
      "compound": "Eloralintide",
      "compoundSlug": "eloralintide",
      "compoundAliases": [
        "LY3841136",
        "eloralintide peptide",
        "selective amylin receptor agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Eloralintide in Saskatchewan",
      "boundedAnswer": "Eloralintide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide",
      "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrilintide-alberta",
      "compound": "Cagrilintide",
      "compoundSlug": "cagrilintide",
      "compoundAliases": [
        "AM833",
        "NNC0174-0833"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Cagrilintide in Alberta",
      "boundedAnswer": "Cagrilintide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrilintide-british-columbia",
      "compound": "Cagrilintide",
      "compoundSlug": "cagrilintide",
      "compoundAliases": [
        "AM833",
        "NNC0174-0833"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Cagrilintide in British Columbia",
      "boundedAnswer": "Cagrilintide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrilintide-manitoba",
      "compound": "Cagrilintide",
      "compoundSlug": "cagrilintide",
      "compoundAliases": [
        "AM833",
        "NNC0174-0833"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Cagrilintide in Manitoba",
      "boundedAnswer": "Cagrilintide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrilintide-new-brunswick",
      "compound": "Cagrilintide",
      "compoundSlug": "cagrilintide",
      "compoundAliases": [
        "AM833",
        "NNC0174-0833"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Cagrilintide in New Brunswick",
      "boundedAnswer": "Cagrilintide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrilintide-newfoundland-and-labrador",
      "compound": "Cagrilintide",
      "compoundSlug": "cagrilintide",
      "compoundAliases": [
        "AM833",
        "NNC0174-0833"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Cagrilintide in Newfoundland and Labrador",
      "boundedAnswer": "Cagrilintide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrilintide-nova-scotia",
      "compound": "Cagrilintide",
      "compoundSlug": "cagrilintide",
      "compoundAliases": [
        "AM833",
        "NNC0174-0833"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Cagrilintide in Nova Scotia",
      "boundedAnswer": "Cagrilintide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrilintide-ontario",
      "compound": "Cagrilintide",
      "compoundSlug": "cagrilintide",
      "compoundAliases": [
        "AM833",
        "NNC0174-0833"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Cagrilintide in Ontario",
      "boundedAnswer": "Cagrilintide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrilintide-prince-edward-island",
      "compound": "Cagrilintide",
      "compoundSlug": "cagrilintide",
      "compoundAliases": [
        "AM833",
        "NNC0174-0833"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Cagrilintide in Prince Edward Island",
      "boundedAnswer": "Cagrilintide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrilintide-quebec",
      "compound": "Cagrilintide",
      "compoundSlug": "cagrilintide",
      "compoundAliases": [
        "AM833",
        "NNC0174-0833"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Cagrilintide in Quebec",
      "boundedAnswer": "Cagrilintide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrilintide-saskatchewan",
      "compound": "Cagrilintide",
      "compoundSlug": "cagrilintide",
      "compoundAliases": [
        "AM833",
        "NNC0174-0833"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Cagrilintide in Saskatchewan",
      "boundedAnswer": "Cagrilintide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries"
    },
    {
      "recordId": "pl-canada-province-petrelintide-alberta",
      "compound": "Petrelintide",
      "compoundSlug": "petrelintide",
      "compoundAliases": [
        "ZP8396",
        "long-acting amylin analogue"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Petrelintide in Alberta",
      "boundedAnswer": "Petrelintide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide",
      "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries"
    },
    {
      "recordId": "pl-canada-province-petrelintide-british-columbia",
      "compound": "Petrelintide",
      "compoundSlug": "petrelintide",
      "compoundAliases": [
        "ZP8396",
        "long-acting amylin analogue"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Petrelintide in British Columbia",
      "boundedAnswer": "Petrelintide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide",
      "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries"
    },
    {
      "recordId": "pl-canada-province-petrelintide-manitoba",
      "compound": "Petrelintide",
      "compoundSlug": "petrelintide",
      "compoundAliases": [
        "ZP8396",
        "long-acting amylin analogue"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Petrelintide in Manitoba",
      "boundedAnswer": "Petrelintide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide",
      "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries"
    },
    {
      "recordId": "pl-canada-province-petrelintide-new-brunswick",
      "compound": "Petrelintide",
      "compoundSlug": "petrelintide",
      "compoundAliases": [
        "ZP8396",
        "long-acting amylin analogue"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Petrelintide in New Brunswick",
      "boundedAnswer": "Petrelintide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide",
      "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries"
    },
    {
      "recordId": "pl-canada-province-petrelintide-newfoundland-and-labrador",
      "compound": "Petrelintide",
      "compoundSlug": "petrelintide",
      "compoundAliases": [
        "ZP8396",
        "long-acting amylin analogue"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Petrelintide in Newfoundland and Labrador",
      "boundedAnswer": "Petrelintide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide",
      "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries"
    },
    {
      "recordId": "pl-canada-province-petrelintide-nova-scotia",
      "compound": "Petrelintide",
      "compoundSlug": "petrelintide",
      "compoundAliases": [
        "ZP8396",
        "long-acting amylin analogue"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Petrelintide in Nova Scotia",
      "boundedAnswer": "Petrelintide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide",
      "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries"
    },
    {
      "recordId": "pl-canada-province-petrelintide-ontario",
      "compound": "Petrelintide",
      "compoundSlug": "petrelintide",
      "compoundAliases": [
        "ZP8396",
        "long-acting amylin analogue"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Petrelintide in Ontario",
      "boundedAnswer": "Petrelintide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide",
      "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries"
    },
    {
      "recordId": "pl-canada-province-petrelintide-prince-edward-island",
      "compound": "Petrelintide",
      "compoundSlug": "petrelintide",
      "compoundAliases": [
        "ZP8396",
        "long-acting amylin analogue"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Petrelintide in Prince Edward Island",
      "boundedAnswer": "Petrelintide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide",
      "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries"
    },
    {
      "recordId": "pl-canada-province-petrelintide-quebec",
      "compound": "Petrelintide",
      "compoundSlug": "petrelintide",
      "compoundAliases": [
        "ZP8396",
        "long-acting amylin analogue"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Petrelintide in Quebec",
      "boundedAnswer": "Petrelintide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide",
      "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries"
    },
    {
      "recordId": "pl-canada-province-petrelintide-saskatchewan",
      "compound": "Petrelintide",
      "compoundSlug": "petrelintide",
      "compoundAliases": [
        "ZP8396",
        "long-acting amylin analogue"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Petrelintide in Saskatchewan",
      "boundedAnswer": "Petrelintide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide",
      "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries"
    },
    {
      "recordId": "pl-canada-province-cagrisema-alberta",
      "compound": "CagriSema",
      "compoundSlug": "cagrisema",
      "compoundAliases": [
        "cagrilintide + semaglutide",
        "REDEFINE 1",
        "REIMAGINE 1-3"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "CagriSema in Alberta",
      "boundedAnswer": "CagriSema in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries"
    },
    {
      "recordId": "pl-canada-province-cagrisema-british-columbia",
      "compound": "CagriSema",
      "compoundSlug": "cagrisema",
      "compoundAliases": [
        "cagrilintide + semaglutide",
        "REDEFINE 1",
        "REIMAGINE 1-3"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "CagriSema in British Columbia",
      "boundedAnswer": "CagriSema in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries"
    },
    {
      "recordId": "pl-canada-province-cagrisema-manitoba",
      "compound": "CagriSema",
      "compoundSlug": "cagrisema",
      "compoundAliases": [
        "cagrilintide + semaglutide",
        "REDEFINE 1",
        "REIMAGINE 1-3"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "CagriSema in Manitoba",
      "boundedAnswer": "CagriSema in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries"
    },
    {
      "recordId": "pl-canada-province-cagrisema-new-brunswick",
      "compound": "CagriSema",
      "compoundSlug": "cagrisema",
      "compoundAliases": [
        "cagrilintide + semaglutide",
        "REDEFINE 1",
        "REIMAGINE 1-3"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "CagriSema in New Brunswick",
      "boundedAnswer": "CagriSema in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries"
    },
    {
      "recordId": "pl-canada-province-cagrisema-newfoundland-and-labrador",
      "compound": "CagriSema",
      "compoundSlug": "cagrisema",
      "compoundAliases": [
        "cagrilintide + semaglutide",
        "REDEFINE 1",
        "REIMAGINE 1-3"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "CagriSema in Newfoundland and Labrador",
      "boundedAnswer": "CagriSema in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries"
    },
    {
      "recordId": "pl-canada-province-cagrisema-nova-scotia",
      "compound": "CagriSema",
      "compoundSlug": "cagrisema",
      "compoundAliases": [
        "cagrilintide + semaglutide",
        "REDEFINE 1",
        "REIMAGINE 1-3"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "CagriSema in Nova Scotia",
      "boundedAnswer": "CagriSema in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries"
    },
    {
      "recordId": "pl-canada-province-cagrisema-ontario",
      "compound": "CagriSema",
      "compoundSlug": "cagrisema",
      "compoundAliases": [
        "cagrilintide + semaglutide",
        "REDEFINE 1",
        "REIMAGINE 1-3"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "CagriSema in Ontario",
      "boundedAnswer": "CagriSema in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries"
    },
    {
      "recordId": "pl-canada-province-cagrisema-prince-edward-island",
      "compound": "CagriSema",
      "compoundSlug": "cagrisema",
      "compoundAliases": [
        "cagrilintide + semaglutide",
        "REDEFINE 1",
        "REIMAGINE 1-3"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "CagriSema in Prince Edward Island",
      "boundedAnswer": "CagriSema in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries"
    },
    {
      "recordId": "pl-canada-province-cagrisema-quebec",
      "compound": "CagriSema",
      "compoundSlug": "cagrisema",
      "compoundAliases": [
        "cagrilintide + semaglutide",
        "REDEFINE 1",
        "REIMAGINE 1-3"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "CagriSema in Quebec",
      "boundedAnswer": "CagriSema in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries"
    },
    {
      "recordId": "pl-canada-province-cagrisema-saskatchewan",
      "compound": "CagriSema",
      "compoundSlug": "cagrisema",
      "compoundAliases": [
        "cagrilintide + semaglutide",
        "REDEFINE 1",
        "REIMAGINE 1-3"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "CagriSema in Saskatchewan",
      "boundedAnswer": "CagriSema in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema",
      "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries"
    },
    {
      "recordId": "pl-canada-province-maritide-alberta",
      "compound": "MariTide",
      "compoundSlug": "maritide",
      "compoundAliases": [
        "maridebart cafraglutide",
        "AMG 133"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "MariTide in Alberta",
      "boundedAnswer": "MariTide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide",
      "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries"
    },
    {
      "recordId": "pl-canada-province-maritide-british-columbia",
      "compound": "MariTide",
      "compoundSlug": "maritide",
      "compoundAliases": [
        "maridebart cafraglutide",
        "AMG 133"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "MariTide in British Columbia",
      "boundedAnswer": "MariTide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide",
      "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries"
    },
    {
      "recordId": "pl-canada-province-maritide-manitoba",
      "compound": "MariTide",
      "compoundSlug": "maritide",
      "compoundAliases": [
        "maridebart cafraglutide",
        "AMG 133"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "MariTide in Manitoba",
      "boundedAnswer": "MariTide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide",
      "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries"
    },
    {
      "recordId": "pl-canada-province-maritide-new-brunswick",
      "compound": "MariTide",
      "compoundSlug": "maritide",
      "compoundAliases": [
        "maridebart cafraglutide",
        "AMG 133"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "MariTide in New Brunswick",
      "boundedAnswer": "MariTide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide",
      "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries"
    },
    {
      "recordId": "pl-canada-province-maritide-newfoundland-and-labrador",
      "compound": "MariTide",
      "compoundSlug": "maritide",
      "compoundAliases": [
        "maridebart cafraglutide",
        "AMG 133"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "MariTide in Newfoundland and Labrador",
      "boundedAnswer": "MariTide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide",
      "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries"
    },
    {
      "recordId": "pl-canada-province-maritide-nova-scotia",
      "compound": "MariTide",
      "compoundSlug": "maritide",
      "compoundAliases": [
        "maridebart cafraglutide",
        "AMG 133"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "MariTide in Nova Scotia",
      "boundedAnswer": "MariTide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide",
      "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries"
    },
    {
      "recordId": "pl-canada-province-maritide-ontario",
      "compound": "MariTide",
      "compoundSlug": "maritide",
      "compoundAliases": [
        "maridebart cafraglutide",
        "AMG 133"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "MariTide in Ontario",
      "boundedAnswer": "MariTide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide",
      "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries"
    },
    {
      "recordId": "pl-canada-province-maritide-prince-edward-island",
      "compound": "MariTide",
      "compoundSlug": "maritide",
      "compoundAliases": [
        "maridebart cafraglutide",
        "AMG 133"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "MariTide in Prince Edward Island",
      "boundedAnswer": "MariTide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide",
      "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries"
    },
    {
      "recordId": "pl-canada-province-maritide-quebec",
      "compound": "MariTide",
      "compoundSlug": "maritide",
      "compoundAliases": [
        "maridebart cafraglutide",
        "AMG 133"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "MariTide in Quebec",
      "boundedAnswer": "MariTide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide",
      "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries"
    },
    {
      "recordId": "pl-canada-province-maritide-saskatchewan",
      "compound": "MariTide",
      "compoundSlug": "maritide",
      "compoundAliases": [
        "maridebart cafraglutide",
        "AMG 133"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "MariTide in Saskatchewan",
      "boundedAnswer": "MariTide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide",
      "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries"
    },
    {
      "recordId": "pl-canada-province-survodutide-alberta",
      "compound": "Survodutide",
      "compoundSlug": "survodutide",
      "compoundAliases": [
        "BI 456906",
        "glucagon/GLP-1 dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Survodutide in Alberta",
      "boundedAnswer": "Survodutide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide",
      "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries"
    },
    {
      "recordId": "pl-canada-province-survodutide-british-columbia",
      "compound": "Survodutide",
      "compoundSlug": "survodutide",
      "compoundAliases": [
        "BI 456906",
        "glucagon/GLP-1 dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Survodutide in British Columbia",
      "boundedAnswer": "Survodutide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide",
      "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries"
    },
    {
      "recordId": "pl-canada-province-survodutide-manitoba",
      "compound": "Survodutide",
      "compoundSlug": "survodutide",
      "compoundAliases": [
        "BI 456906",
        "glucagon/GLP-1 dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Survodutide in Manitoba",
      "boundedAnswer": "Survodutide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide",
      "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries"
    },
    {
      "recordId": "pl-canada-province-survodutide-new-brunswick",
      "compound": "Survodutide",
      "compoundSlug": "survodutide",
      "compoundAliases": [
        "BI 456906",
        "glucagon/GLP-1 dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Survodutide in New Brunswick",
      "boundedAnswer": "Survodutide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide",
      "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries"
    },
    {
      "recordId": "pl-canada-province-survodutide-newfoundland-and-labrador",
      "compound": "Survodutide",
      "compoundSlug": "survodutide",
      "compoundAliases": [
        "BI 456906",
        "glucagon/GLP-1 dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Survodutide in Newfoundland and Labrador",
      "boundedAnswer": "Survodutide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide",
      "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries"
    },
    {
      "recordId": "pl-canada-province-survodutide-nova-scotia",
      "compound": "Survodutide",
      "compoundSlug": "survodutide",
      "compoundAliases": [
        "BI 456906",
        "glucagon/GLP-1 dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Survodutide in Nova Scotia",
      "boundedAnswer": "Survodutide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide",
      "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries"
    },
    {
      "recordId": "pl-canada-province-survodutide-ontario",
      "compound": "Survodutide",
      "compoundSlug": "survodutide",
      "compoundAliases": [
        "BI 456906",
        "glucagon/GLP-1 dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Survodutide in Ontario",
      "boundedAnswer": "Survodutide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide",
      "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries"
    },
    {
      "recordId": "pl-canada-province-survodutide-prince-edward-island",
      "compound": "Survodutide",
      "compoundSlug": "survodutide",
      "compoundAliases": [
        "BI 456906",
        "glucagon/GLP-1 dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Survodutide in Prince Edward Island",
      "boundedAnswer": "Survodutide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide",
      "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries"
    },
    {
      "recordId": "pl-canada-province-survodutide-quebec",
      "compound": "Survodutide",
      "compoundSlug": "survodutide",
      "compoundAliases": [
        "BI 456906",
        "glucagon/GLP-1 dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Survodutide in Quebec",
      "boundedAnswer": "Survodutide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide",
      "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries"
    },
    {
      "recordId": "pl-canada-province-survodutide-saskatchewan",
      "compound": "Survodutide",
      "compoundSlug": "survodutide",
      "compoundAliases": [
        "BI 456906",
        "glucagon/GLP-1 dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Survodutide in Saskatchewan",
      "boundedAnswer": "Survodutide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide",
      "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries"
    },
    {
      "recordId": "pl-canada-province-vk2735-alberta",
      "compound": "VK2735",
      "compoundSlug": "vk2735",
      "compoundAliases": [
        "Viking VK2735",
        "oral VK2735",
        "GLP-1/GIP dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "VK2735 in Alberta",
      "boundedAnswer": "VK2735 in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735",
      "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries"
    },
    {
      "recordId": "pl-canada-province-vk2735-british-columbia",
      "compound": "VK2735",
      "compoundSlug": "vk2735",
      "compoundAliases": [
        "Viking VK2735",
        "oral VK2735",
        "GLP-1/GIP dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "VK2735 in British Columbia",
      "boundedAnswer": "VK2735 in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735",
      "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries"
    },
    {
      "recordId": "pl-canada-province-vk2735-manitoba",
      "compound": "VK2735",
      "compoundSlug": "vk2735",
      "compoundAliases": [
        "Viking VK2735",
        "oral VK2735",
        "GLP-1/GIP dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "VK2735 in Manitoba",
      "boundedAnswer": "VK2735 in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735",
      "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries"
    },
    {
      "recordId": "pl-canada-province-vk2735-new-brunswick",
      "compound": "VK2735",
      "compoundSlug": "vk2735",
      "compoundAliases": [
        "Viking VK2735",
        "oral VK2735",
        "GLP-1/GIP dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "VK2735 in New Brunswick",
      "boundedAnswer": "VK2735 in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735",
      "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries"
    },
    {
      "recordId": "pl-canada-province-vk2735-newfoundland-and-labrador",
      "compound": "VK2735",
      "compoundSlug": "vk2735",
      "compoundAliases": [
        "Viking VK2735",
        "oral VK2735",
        "GLP-1/GIP dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "VK2735 in Newfoundland and Labrador",
      "boundedAnswer": "VK2735 in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735",
      "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries"
    },
    {
      "recordId": "pl-canada-province-vk2735-nova-scotia",
      "compound": "VK2735",
      "compoundSlug": "vk2735",
      "compoundAliases": [
        "Viking VK2735",
        "oral VK2735",
        "GLP-1/GIP dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "VK2735 in Nova Scotia",
      "boundedAnswer": "VK2735 in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735",
      "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries"
    },
    {
      "recordId": "pl-canada-province-vk2735-ontario",
      "compound": "VK2735",
      "compoundSlug": "vk2735",
      "compoundAliases": [
        "Viking VK2735",
        "oral VK2735",
        "GLP-1/GIP dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "VK2735 in Ontario",
      "boundedAnswer": "VK2735 in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735",
      "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries"
    },
    {
      "recordId": "pl-canada-province-vk2735-prince-edward-island",
      "compound": "VK2735",
      "compoundSlug": "vk2735",
      "compoundAliases": [
        "Viking VK2735",
        "oral VK2735",
        "GLP-1/GIP dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "VK2735 in Prince Edward Island",
      "boundedAnswer": "VK2735 in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735",
      "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries"
    },
    {
      "recordId": "pl-canada-province-vk2735-quebec",
      "compound": "VK2735",
      "compoundSlug": "vk2735",
      "compoundAliases": [
        "Viking VK2735",
        "oral VK2735",
        "GLP-1/GIP dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "VK2735 in Quebec",
      "boundedAnswer": "VK2735 in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735",
      "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries"
    },
    {
      "recordId": "pl-canada-province-vk2735-saskatchewan",
      "compound": "VK2735",
      "compoundSlug": "vk2735",
      "compoundAliases": [
        "Viking VK2735",
        "oral VK2735",
        "GLP-1/GIP dual agonist"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "VK2735 in Saskatchewan",
      "boundedAnswer": "VK2735 in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735",
      "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries"
    },
    {
      "recordId": "pl-canada-province-pemvidutide-alberta",
      "compound": "Pemvidutide",
      "compoundSlug": "pemvidutide",
      "compoundAliases": [
        "ALT-801",
        "balanced GLP-1/glucagon dual agonist",
        "Altimmune pemvidutide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Pemvidutide in Alberta",
      "boundedAnswer": "Pemvidutide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide",
      "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries"
    },
    {
      "recordId": "pl-canada-province-pemvidutide-british-columbia",
      "compound": "Pemvidutide",
      "compoundSlug": "pemvidutide",
      "compoundAliases": [
        "ALT-801",
        "balanced GLP-1/glucagon dual agonist",
        "Altimmune pemvidutide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Pemvidutide in British Columbia",
      "boundedAnswer": "Pemvidutide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide",
      "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries"
    },
    {
      "recordId": "pl-canada-province-pemvidutide-manitoba",
      "compound": "Pemvidutide",
      "compoundSlug": "pemvidutide",
      "compoundAliases": [
        "ALT-801",
        "balanced GLP-1/glucagon dual agonist",
        "Altimmune pemvidutide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Pemvidutide in Manitoba",
      "boundedAnswer": "Pemvidutide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide",
      "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries"
    },
    {
      "recordId": "pl-canada-province-pemvidutide-new-brunswick",
      "compound": "Pemvidutide",
      "compoundSlug": "pemvidutide",
      "compoundAliases": [
        "ALT-801",
        "balanced GLP-1/glucagon dual agonist",
        "Altimmune pemvidutide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Pemvidutide in New Brunswick",
      "boundedAnswer": "Pemvidutide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide",
      "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries"
    },
    {
      "recordId": "pl-canada-province-pemvidutide-newfoundland-and-labrador",
      "compound": "Pemvidutide",
      "compoundSlug": "pemvidutide",
      "compoundAliases": [
        "ALT-801",
        "balanced GLP-1/glucagon dual agonist",
        "Altimmune pemvidutide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Pemvidutide in Newfoundland and Labrador",
      "boundedAnswer": "Pemvidutide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide",
      "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries"
    },
    {
      "recordId": "pl-canada-province-pemvidutide-nova-scotia",
      "compound": "Pemvidutide",
      "compoundSlug": "pemvidutide",
      "compoundAliases": [
        "ALT-801",
        "balanced GLP-1/glucagon dual agonist",
        "Altimmune pemvidutide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Pemvidutide in Nova Scotia",
      "boundedAnswer": "Pemvidutide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide",
      "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries"
    },
    {
      "recordId": "pl-canada-province-pemvidutide-ontario",
      "compound": "Pemvidutide",
      "compoundSlug": "pemvidutide",
      "compoundAliases": [
        "ALT-801",
        "balanced GLP-1/glucagon dual agonist",
        "Altimmune pemvidutide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Pemvidutide in Ontario",
      "boundedAnswer": "Pemvidutide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide",
      "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries"
    },
    {
      "recordId": "pl-canada-province-pemvidutide-prince-edward-island",
      "compound": "Pemvidutide",
      "compoundSlug": "pemvidutide",
      "compoundAliases": [
        "ALT-801",
        "balanced GLP-1/glucagon dual agonist",
        "Altimmune pemvidutide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Pemvidutide in Prince Edward Island",
      "boundedAnswer": "Pemvidutide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide",
      "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries"
    },
    {
      "recordId": "pl-canada-province-pemvidutide-quebec",
      "compound": "Pemvidutide",
      "compoundSlug": "pemvidutide",
      "compoundAliases": [
        "ALT-801",
        "balanced GLP-1/glucagon dual agonist",
        "Altimmune pemvidutide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Pemvidutide in Quebec",
      "boundedAnswer": "Pemvidutide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide",
      "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries"
    },
    {
      "recordId": "pl-canada-province-pemvidutide-saskatchewan",
      "compound": "Pemvidutide",
      "compoundSlug": "pemvidutide",
      "compoundAliases": [
        "ALT-801",
        "balanced GLP-1/glucagon dual agonist",
        "Altimmune pemvidutide"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Pemvidutide in Saskatchewan",
      "boundedAnswer": "Pemvidutide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide",
      "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries"
    },
    {
      "recordId": "pl-canada-province-amycretin-alberta",
      "compound": "Amycretin / Zenagamtide",
      "compoundSlug": "amycretin",
      "compoundAliases": [
        "amycretin",
        "NNC0487-0111",
        "AMAZE 7"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Amycretin / Zenagamtide in Alberta",
      "boundedAnswer": "Amycretin / Zenagamtide in Alberta refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin",
      "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries"
    },
    {
      "recordId": "pl-canada-province-amycretin-british-columbia",
      "compound": "Amycretin / Zenagamtide",
      "compoundSlug": "amycretin",
      "compoundAliases": [
        "amycretin",
        "NNC0487-0111",
        "AMAZE 7"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Amycretin / Zenagamtide in British Columbia",
      "boundedAnswer": "Amycretin / Zenagamtide in British Columbia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin",
      "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries"
    },
    {
      "recordId": "pl-canada-province-amycretin-manitoba",
      "compound": "Amycretin / Zenagamtide",
      "compoundSlug": "amycretin",
      "compoundAliases": [
        "amycretin",
        "NNC0487-0111",
        "AMAZE 7"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Amycretin / Zenagamtide in Manitoba",
      "boundedAnswer": "Amycretin / Zenagamtide in Manitoba refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin",
      "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries"
    },
    {
      "recordId": "pl-canada-province-amycretin-new-brunswick",
      "compound": "Amycretin / Zenagamtide",
      "compoundSlug": "amycretin",
      "compoundAliases": [
        "amycretin",
        "NNC0487-0111",
        "AMAZE 7"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Amycretin / Zenagamtide in New Brunswick",
      "boundedAnswer": "Amycretin / Zenagamtide in New Brunswick refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin",
      "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries"
    },
    {
      "recordId": "pl-canada-province-amycretin-newfoundland-and-labrador",
      "compound": "Amycretin / Zenagamtide",
      "compoundSlug": "amycretin",
      "compoundAliases": [
        "amycretin",
        "NNC0487-0111",
        "AMAZE 7"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Amycretin / Zenagamtide in Newfoundland and Labrador",
      "boundedAnswer": "Amycretin / Zenagamtide in Newfoundland and Labrador refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin",
      "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries"
    },
    {
      "recordId": "pl-canada-province-amycretin-nova-scotia",
      "compound": "Amycretin / Zenagamtide",
      "compoundSlug": "amycretin",
      "compoundAliases": [
        "amycretin",
        "NNC0487-0111",
        "AMAZE 7"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Amycretin / Zenagamtide in Nova Scotia",
      "boundedAnswer": "Amycretin / Zenagamtide in Nova Scotia refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin",
      "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries"
    },
    {
      "recordId": "pl-canada-province-amycretin-ontario",
      "compound": "Amycretin / Zenagamtide",
      "compoundSlug": "amycretin",
      "compoundAliases": [
        "amycretin",
        "NNC0487-0111",
        "AMAZE 7"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Amycretin / Zenagamtide in Ontario",
      "boundedAnswer": "Amycretin / Zenagamtide in Ontario refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin",
      "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries"
    },
    {
      "recordId": "pl-canada-province-amycretin-prince-edward-island",
      "compound": "Amycretin / Zenagamtide",
      "compoundSlug": "amycretin",
      "compoundAliases": [
        "amycretin",
        "NNC0487-0111",
        "AMAZE 7"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Amycretin / Zenagamtide in Prince Edward Island",
      "boundedAnswer": "Amycretin / Zenagamtide in Prince Edward Island refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin",
      "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries"
    },
    {
      "recordId": "pl-canada-province-amycretin-quebec",
      "compound": "Amycretin / Zenagamtide",
      "compoundSlug": "amycretin",
      "compoundAliases": [
        "amycretin",
        "NNC0487-0111",
        "AMAZE 7"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Amycretin / Zenagamtide in Quebec",
      "boundedAnswer": "Amycretin / Zenagamtide in Quebec refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin",
      "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries"
    },
    {
      "recordId": "pl-canada-province-amycretin-saskatchewan",
      "compound": "Amycretin / Zenagamtide",
      "compoundSlug": "amycretin",
      "compoundAliases": [
        "amycretin",
        "NNC0487-0111",
        "AMAZE 7"
      ],
      "evidenceLane": "Clinical pipeline profile",
      "identityStatus": "Investigational clinical program",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Amycretin / Zenagamtide in Saskatchewan",
      "boundedAnswer": "Amycretin / Zenagamtide in Saskatchewan refers first to an investigational clinical program, not an approved Canadian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin",
      "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414",
      "identitySourcePublisher": "ClinicalTrials.gov",
      "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries"
    },
    {
      "recordId": "pl-canada-province-tirzepatide-alberta",
      "compound": "Tirzepatide",
      "compoundSlug": "tirzepatide",
      "compoundAliases": [
        "tirzepatide",
        "Zepbound",
        "LY3298176",
        "NDA 217806",
        "GIP and GLP-1 receptor agonist"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "US FDA medicine reference",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Tirzepatide in Alberta",
      "boundedAnswer": "Tirzepatide in Alberta begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound",
      "identitySourceLabel": "Current ZEPBOUND prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries"
    },
    {
      "recordId": "pl-canada-province-tirzepatide-british-columbia",
      "compound": "Tirzepatide",
      "compoundSlug": "tirzepatide",
      "compoundAliases": [
        "tirzepatide",
        "Zepbound",
        "LY3298176",
        "NDA 217806",
        "GIP and GLP-1 receptor agonist"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "US FDA medicine reference",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Tirzepatide in British Columbia",
      "boundedAnswer": "Tirzepatide in British Columbia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound",
      "identitySourceLabel": "Current ZEPBOUND prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries"
    },
    {
      "recordId": "pl-canada-province-tirzepatide-manitoba",
      "compound": "Tirzepatide",
      "compoundSlug": "tirzepatide",
      "compoundAliases": [
        "tirzepatide",
        "Zepbound",
        "LY3298176",
        "NDA 217806",
        "GIP and GLP-1 receptor agonist"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "US FDA medicine reference",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Tirzepatide in Manitoba",
      "boundedAnswer": "Tirzepatide in Manitoba begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound",
      "identitySourceLabel": "Current ZEPBOUND prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries"
    },
    {
      "recordId": "pl-canada-province-tirzepatide-new-brunswick",
      "compound": "Tirzepatide",
      "compoundSlug": "tirzepatide",
      "compoundAliases": [
        "tirzepatide",
        "Zepbound",
        "LY3298176",
        "NDA 217806",
        "GIP and GLP-1 receptor agonist"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "US FDA medicine reference",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Tirzepatide in New Brunswick",
      "boundedAnswer": "Tirzepatide in New Brunswick begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound",
      "identitySourceLabel": "Current ZEPBOUND prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries"
    },
    {
      "recordId": "pl-canada-province-tirzepatide-newfoundland-and-labrador",
      "compound": "Tirzepatide",
      "compoundSlug": "tirzepatide",
      "compoundAliases": [
        "tirzepatide",
        "Zepbound",
        "LY3298176",
        "NDA 217806",
        "GIP and GLP-1 receptor agonist"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "US FDA medicine reference",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Tirzepatide in Newfoundland and Labrador",
      "boundedAnswer": "Tirzepatide in Newfoundland and Labrador begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound",
      "identitySourceLabel": "Current ZEPBOUND prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries"
    },
    {
      "recordId": "pl-canada-province-tirzepatide-nova-scotia",
      "compound": "Tirzepatide",
      "compoundSlug": "tirzepatide",
      "compoundAliases": [
        "tirzepatide",
        "Zepbound",
        "LY3298176",
        "NDA 217806",
        "GIP and GLP-1 receptor agonist"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "US FDA medicine reference",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Tirzepatide in Nova Scotia",
      "boundedAnswer": "Tirzepatide in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound",
      "identitySourceLabel": "Current ZEPBOUND prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries"
    },
    {
      "recordId": "pl-canada-province-tirzepatide-ontario",
      "compound": "Tirzepatide",
      "compoundSlug": "tirzepatide",
      "compoundAliases": [
        "tirzepatide",
        "Zepbound",
        "LY3298176",
        "NDA 217806",
        "GIP and GLP-1 receptor agonist"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "US FDA medicine reference",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Tirzepatide in Ontario",
      "boundedAnswer": "Tirzepatide in Ontario begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound",
      "identitySourceLabel": "Current ZEPBOUND prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries"
    },
    {
      "recordId": "pl-canada-province-tirzepatide-prince-edward-island",
      "compound": "Tirzepatide",
      "compoundSlug": "tirzepatide",
      "compoundAliases": [
        "tirzepatide",
        "Zepbound",
        "LY3298176",
        "NDA 217806",
        "GIP and GLP-1 receptor agonist"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "US FDA medicine reference",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Tirzepatide in Prince Edward Island",
      "boundedAnswer": "Tirzepatide in Prince Edward Island begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound",
      "identitySourceLabel": "Current ZEPBOUND prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries"
    },
    {
      "recordId": "pl-canada-province-tirzepatide-quebec",
      "compound": "Tirzepatide",
      "compoundSlug": "tirzepatide",
      "compoundAliases": [
        "tirzepatide",
        "Zepbound",
        "LY3298176",
        "NDA 217806",
        "GIP and GLP-1 receptor agonist"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "US FDA medicine reference",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Tirzepatide in Quebec",
      "boundedAnswer": "Tirzepatide in Quebec begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound",
      "identitySourceLabel": "Current ZEPBOUND prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries"
    },
    {
      "recordId": "pl-canada-province-tirzepatide-saskatchewan",
      "compound": "Tirzepatide",
      "compoundSlug": "tirzepatide",
      "compoundAliases": [
        "tirzepatide",
        "Zepbound",
        "LY3298176",
        "NDA 217806",
        "GIP and GLP-1 receptor agonist"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "US FDA medicine reference",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Tirzepatide in Saskatchewan",
      "boundedAnswer": "Tirzepatide in Saskatchewan begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound",
      "identitySourceLabel": "Current ZEPBOUND prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries"
    },
    {
      "recordId": "pl-canada-province-orforglipron-alberta",
      "compound": "Orforglipron / Foundayo",
      "compoundSlug": "orforglipron",
      "compoundAliases": [
        "orforglipron",
        "Foundayo",
        "LY3502970",
        "NDA 220934",
        "oral GLP-1",
        "nonpeptide GLP-1",
        "non-peptide GLP-1",
        "weight loss pill"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with country-specific status elsewhere",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Orforglipron / Foundayo in Alberta",
      "boundedAnswer": "Orforglipron / Foundayo in Alberta begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo",
      "identitySourceLabel": "Current FOUNDAYO prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries"
    },
    {
      "recordId": "pl-canada-province-orforglipron-british-columbia",
      "compound": "Orforglipron / Foundayo",
      "compoundSlug": "orforglipron",
      "compoundAliases": [
        "orforglipron",
        "Foundayo",
        "LY3502970",
        "NDA 220934",
        "oral GLP-1",
        "nonpeptide GLP-1",
        "non-peptide GLP-1",
        "weight loss pill"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with country-specific status elsewhere",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Orforglipron / Foundayo in British Columbia",
      "boundedAnswer": "Orforglipron / Foundayo in British Columbia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo",
      "identitySourceLabel": "Current FOUNDAYO prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries"
    },
    {
      "recordId": "pl-canada-province-orforglipron-manitoba",
      "compound": "Orforglipron / Foundayo",
      "compoundSlug": "orforglipron",
      "compoundAliases": [
        "orforglipron",
        "Foundayo",
        "LY3502970",
        "NDA 220934",
        "oral GLP-1",
        "nonpeptide GLP-1",
        "non-peptide GLP-1",
        "weight loss pill"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with country-specific status elsewhere",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Orforglipron / Foundayo in Manitoba",
      "boundedAnswer": "Orforglipron / Foundayo in Manitoba begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo",
      "identitySourceLabel": "Current FOUNDAYO prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries"
    },
    {
      "recordId": "pl-canada-province-orforglipron-new-brunswick",
      "compound": "Orforglipron / Foundayo",
      "compoundSlug": "orforglipron",
      "compoundAliases": [
        "orforglipron",
        "Foundayo",
        "LY3502970",
        "NDA 220934",
        "oral GLP-1",
        "nonpeptide GLP-1",
        "non-peptide GLP-1",
        "weight loss pill"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with country-specific status elsewhere",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Orforglipron / Foundayo in New Brunswick",
      "boundedAnswer": "Orforglipron / Foundayo in New Brunswick begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo",
      "identitySourceLabel": "Current FOUNDAYO prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries"
    },
    {
      "recordId": "pl-canada-province-orforglipron-newfoundland-and-labrador",
      "compound": "Orforglipron / Foundayo",
      "compoundSlug": "orforglipron",
      "compoundAliases": [
        "orforglipron",
        "Foundayo",
        "LY3502970",
        "NDA 220934",
        "oral GLP-1",
        "nonpeptide GLP-1",
        "non-peptide GLP-1",
        "weight loss pill"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with country-specific status elsewhere",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Orforglipron / Foundayo in Newfoundland and Labrador",
      "boundedAnswer": "Orforglipron / Foundayo in Newfoundland and Labrador begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo",
      "identitySourceLabel": "Current FOUNDAYO prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries"
    },
    {
      "recordId": "pl-canada-province-orforglipron-nova-scotia",
      "compound": "Orforglipron / Foundayo",
      "compoundSlug": "orforglipron",
      "compoundAliases": [
        "orforglipron",
        "Foundayo",
        "LY3502970",
        "NDA 220934",
        "oral GLP-1",
        "nonpeptide GLP-1",
        "non-peptide GLP-1",
        "weight loss pill"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with country-specific status elsewhere",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Orforglipron / Foundayo in Nova Scotia",
      "boundedAnswer": "Orforglipron / Foundayo in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo",
      "identitySourceLabel": "Current FOUNDAYO prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries"
    },
    {
      "recordId": "pl-canada-province-orforglipron-ontario",
      "compound": "Orforglipron / Foundayo",
      "compoundSlug": "orforglipron",
      "compoundAliases": [
        "orforglipron",
        "Foundayo",
        "LY3502970",
        "NDA 220934",
        "oral GLP-1",
        "nonpeptide GLP-1",
        "non-peptide GLP-1",
        "weight loss pill"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with country-specific status elsewhere",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Orforglipron / Foundayo in Ontario",
      "boundedAnswer": "Orforglipron / Foundayo in Ontario begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo",
      "identitySourceLabel": "Current FOUNDAYO prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries"
    },
    {
      "recordId": "pl-canada-province-orforglipron-prince-edward-island",
      "compound": "Orforglipron / Foundayo",
      "compoundSlug": "orforglipron",
      "compoundAliases": [
        "orforglipron",
        "Foundayo",
        "LY3502970",
        "NDA 220934",
        "oral GLP-1",
        "nonpeptide GLP-1",
        "non-peptide GLP-1",
        "weight loss pill"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with country-specific status elsewhere",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Orforglipron / Foundayo in Prince Edward Island",
      "boundedAnswer": "Orforglipron / Foundayo in Prince Edward Island begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo",
      "identitySourceLabel": "Current FOUNDAYO prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries"
    },
    {
      "recordId": "pl-canada-province-orforglipron-quebec",
      "compound": "Orforglipron / Foundayo",
      "compoundSlug": "orforglipron",
      "compoundAliases": [
        "orforglipron",
        "Foundayo",
        "LY3502970",
        "NDA 220934",
        "oral GLP-1",
        "nonpeptide GLP-1",
        "non-peptide GLP-1",
        "weight loss pill"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with country-specific status elsewhere",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Orforglipron / Foundayo in Quebec",
      "boundedAnswer": "Orforglipron / Foundayo in Quebec begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo",
      "identitySourceLabel": "Current FOUNDAYO prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries"
    },
    {
      "recordId": "pl-canada-province-orforglipron-saskatchewan",
      "compound": "Orforglipron / Foundayo",
      "compoundSlug": "orforglipron",
      "compoundAliases": [
        "orforglipron",
        "Foundayo",
        "LY3502970",
        "NDA 220934",
        "oral GLP-1",
        "nonpeptide GLP-1",
        "non-peptide GLP-1",
        "weight loss pill"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with country-specific status elsewhere",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Orforglipron / Foundayo in Saskatchewan",
      "boundedAnswer": "Orforglipron / Foundayo in Saskatchewan begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo",
      "identitySourceLabel": "Current FOUNDAYO prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries"
    },
    {
      "recordId": "pl-canada-province-semaglutide-alberta",
      "compound": "Semaglutide",
      "compoundSlug": "semaglutide",
      "compoundAliases": [
        "semaglutide",
        "Wegovy",
        "NDA 215256",
        "GLP-1 receptor agonist",
        "semaglutide injection",
        "semaglutide tablets",
        "oral Wegovy",
        "Wegovy pill",
        "sémaglutide",
        "semaglutida",
        "Semaglutid",
        "司美格鲁肽",
        "semaglutyd",
        "semaglutid",
        "Ozempic by country",
        "Rybelsus by country"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific approved medicine records in multiple jurisdictions",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Semaglutide in Alberta",
      "boundedAnswer": "Semaglutide in Alberta begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy",
      "identitySourceLabel": "Current WEGOVY prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries"
    },
    {
      "recordId": "pl-canada-province-semaglutide-british-columbia",
      "compound": "Semaglutide",
      "compoundSlug": "semaglutide",
      "compoundAliases": [
        "semaglutide",
        "Wegovy",
        "NDA 215256",
        "GLP-1 receptor agonist",
        "semaglutide injection",
        "semaglutide tablets",
        "oral Wegovy",
        "Wegovy pill",
        "sémaglutide",
        "semaglutida",
        "Semaglutid",
        "司美格鲁肽",
        "semaglutyd",
        "semaglutid",
        "Ozempic by country",
        "Rybelsus by country"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific approved medicine records in multiple jurisdictions",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Semaglutide in British Columbia",
      "boundedAnswer": "Semaglutide in British Columbia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy",
      "identitySourceLabel": "Current WEGOVY prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries"
    },
    {
      "recordId": "pl-canada-province-semaglutide-manitoba",
      "compound": "Semaglutide",
      "compoundSlug": "semaglutide",
      "compoundAliases": [
        "semaglutide",
        "Wegovy",
        "NDA 215256",
        "GLP-1 receptor agonist",
        "semaglutide injection",
        "semaglutide tablets",
        "oral Wegovy",
        "Wegovy pill",
        "sémaglutide",
        "semaglutida",
        "Semaglutid",
        "司美格鲁肽",
        "semaglutyd",
        "semaglutid",
        "Ozempic by country",
        "Rybelsus by country"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific approved medicine records in multiple jurisdictions",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Semaglutide in Manitoba",
      "boundedAnswer": "Semaglutide in Manitoba begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy",
      "identitySourceLabel": "Current WEGOVY prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries"
    },
    {
      "recordId": "pl-canada-province-semaglutide-new-brunswick",
      "compound": "Semaglutide",
      "compoundSlug": "semaglutide",
      "compoundAliases": [
        "semaglutide",
        "Wegovy",
        "NDA 215256",
        "GLP-1 receptor agonist",
        "semaglutide injection",
        "semaglutide tablets",
        "oral Wegovy",
        "Wegovy pill",
        "sémaglutide",
        "semaglutida",
        "Semaglutid",
        "司美格鲁肽",
        "semaglutyd",
        "semaglutid",
        "Ozempic by country",
        "Rybelsus by country"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific approved medicine records in multiple jurisdictions",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Semaglutide in New Brunswick",
      "boundedAnswer": "Semaglutide in New Brunswick begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy",
      "identitySourceLabel": "Current WEGOVY prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries"
    },
    {
      "recordId": "pl-canada-province-semaglutide-newfoundland-and-labrador",
      "compound": "Semaglutide",
      "compoundSlug": "semaglutide",
      "compoundAliases": [
        "semaglutide",
        "Wegovy",
        "NDA 215256",
        "GLP-1 receptor agonist",
        "semaglutide injection",
        "semaglutide tablets",
        "oral Wegovy",
        "Wegovy pill",
        "sémaglutide",
        "semaglutida",
        "Semaglutid",
        "司美格鲁肽",
        "semaglutyd",
        "semaglutid",
        "Ozempic by country",
        "Rybelsus by country"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific approved medicine records in multiple jurisdictions",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Semaglutide in Newfoundland and Labrador",
      "boundedAnswer": "Semaglutide in Newfoundland and Labrador begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy",
      "identitySourceLabel": "Current WEGOVY prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries"
    },
    {
      "recordId": "pl-canada-province-semaglutide-nova-scotia",
      "compound": "Semaglutide",
      "compoundSlug": "semaglutide",
      "compoundAliases": [
        "semaglutide",
        "Wegovy",
        "NDA 215256",
        "GLP-1 receptor agonist",
        "semaglutide injection",
        "semaglutide tablets",
        "oral Wegovy",
        "Wegovy pill",
        "sémaglutide",
        "semaglutida",
        "Semaglutid",
        "司美格鲁肽",
        "semaglutyd",
        "semaglutid",
        "Ozempic by country",
        "Rybelsus by country"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific approved medicine records in multiple jurisdictions",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Semaglutide in Nova Scotia",
      "boundedAnswer": "Semaglutide in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy",
      "identitySourceLabel": "Current WEGOVY prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries"
    },
    {
      "recordId": "pl-canada-province-semaglutide-ontario",
      "compound": "Semaglutide",
      "compoundSlug": "semaglutide",
      "compoundAliases": [
        "semaglutide",
        "Wegovy",
        "NDA 215256",
        "GLP-1 receptor agonist",
        "semaglutide injection",
        "semaglutide tablets",
        "oral Wegovy",
        "Wegovy pill",
        "sémaglutide",
        "semaglutida",
        "Semaglutid",
        "司美格鲁肽",
        "semaglutyd",
        "semaglutid",
        "Ozempic by country",
        "Rybelsus by country"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific approved medicine records in multiple jurisdictions",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Semaglutide in Ontario",
      "boundedAnswer": "Semaglutide in Ontario begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy",
      "identitySourceLabel": "Current WEGOVY prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries"
    },
    {
      "recordId": "pl-canada-province-semaglutide-prince-edward-island",
      "compound": "Semaglutide",
      "compoundSlug": "semaglutide",
      "compoundAliases": [
        "semaglutide",
        "Wegovy",
        "NDA 215256",
        "GLP-1 receptor agonist",
        "semaglutide injection",
        "semaglutide tablets",
        "oral Wegovy",
        "Wegovy pill",
        "sémaglutide",
        "semaglutida",
        "Semaglutid",
        "司美格鲁肽",
        "semaglutyd",
        "semaglutid",
        "Ozempic by country",
        "Rybelsus by country"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific approved medicine records in multiple jurisdictions",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Semaglutide in Prince Edward Island",
      "boundedAnswer": "Semaglutide in Prince Edward Island begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy",
      "identitySourceLabel": "Current WEGOVY prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries"
    },
    {
      "recordId": "pl-canada-province-semaglutide-quebec",
      "compound": "Semaglutide",
      "compoundSlug": "semaglutide",
      "compoundAliases": [
        "semaglutide",
        "Wegovy",
        "NDA 215256",
        "GLP-1 receptor agonist",
        "semaglutide injection",
        "semaglutide tablets",
        "oral Wegovy",
        "Wegovy pill",
        "sémaglutide",
        "semaglutida",
        "Semaglutid",
        "司美格鲁肽",
        "semaglutyd",
        "semaglutid",
        "Ozempic by country",
        "Rybelsus by country"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific approved medicine records in multiple jurisdictions",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Semaglutide in Quebec",
      "boundedAnswer": "Semaglutide in Quebec begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy",
      "identitySourceLabel": "Current WEGOVY prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries"
    },
    {
      "recordId": "pl-canada-province-semaglutide-saskatchewan",
      "compound": "Semaglutide",
      "compoundSlug": "semaglutide",
      "compoundAliases": [
        "semaglutide",
        "Wegovy",
        "NDA 215256",
        "GLP-1 receptor agonist",
        "semaglutide injection",
        "semaglutide tablets",
        "oral Wegovy",
        "Wegovy pill",
        "sémaglutide",
        "semaglutida",
        "Semaglutid",
        "司美格鲁肽",
        "semaglutyd",
        "semaglutid",
        "Ozempic by country",
        "Rybelsus by country"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific approved medicine records in multiple jurisdictions",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Semaglutide in Saskatchewan",
      "boundedAnswer": "Semaglutide in Saskatchewan begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy",
      "identitySourceLabel": "Current WEGOVY prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries"
    },
    {
      "recordId": "pl-canada-province-dsip-alberta",
      "compound": "DSIP / Emideltide",
      "compoundSlug": "dsip",
      "compoundAliases": [
        "Delta sleep-inducing peptide",
        "Emideltide",
        "DSIP nonapeptide",
        "delta sleep-inducing peptide",
        "delta sleep inducing peptide",
        "DSIP peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "FDA-flagged unapproved research-market peptide identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "DSIP / Emideltide in Alberta",
      "boundedAnswer": "DSIP / Emideltide in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/dsip",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries"
    },
    {
      "recordId": "pl-canada-province-dsip-british-columbia",
      "compound": "DSIP / Emideltide",
      "compoundSlug": "dsip",
      "compoundAliases": [
        "Delta sleep-inducing peptide",
        "Emideltide",
        "DSIP nonapeptide",
        "delta sleep-inducing peptide",
        "delta sleep inducing peptide",
        "DSIP peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "FDA-flagged unapproved research-market peptide identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "DSIP / Emideltide in British Columbia",
      "boundedAnswer": "DSIP / Emideltide in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/dsip",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries"
    },
    {
      "recordId": "pl-canada-province-dsip-manitoba",
      "compound": "DSIP / Emideltide",
      "compoundSlug": "dsip",
      "compoundAliases": [
        "Delta sleep-inducing peptide",
        "Emideltide",
        "DSIP nonapeptide",
        "delta sleep-inducing peptide",
        "delta sleep inducing peptide",
        "DSIP peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "FDA-flagged unapproved research-market peptide identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "DSIP / Emideltide in Manitoba",
      "boundedAnswer": "DSIP / Emideltide in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/dsip",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries"
    },
    {
      "recordId": "pl-canada-province-dsip-new-brunswick",
      "compound": "DSIP / Emideltide",
      "compoundSlug": "dsip",
      "compoundAliases": [
        "Delta sleep-inducing peptide",
        "Emideltide",
        "DSIP nonapeptide",
        "delta sleep-inducing peptide",
        "delta sleep inducing peptide",
        "DSIP peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "FDA-flagged unapproved research-market peptide identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "DSIP / Emideltide in New Brunswick",
      "boundedAnswer": "DSIP / Emideltide in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/dsip",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries"
    },
    {
      "recordId": "pl-canada-province-dsip-newfoundland-and-labrador",
      "compound": "DSIP / Emideltide",
      "compoundSlug": "dsip",
      "compoundAliases": [
        "Delta sleep-inducing peptide",
        "Emideltide",
        "DSIP nonapeptide",
        "delta sleep-inducing peptide",
        "delta sleep inducing peptide",
        "DSIP peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "FDA-flagged unapproved research-market peptide identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "DSIP / Emideltide in Newfoundland and Labrador",
      "boundedAnswer": "DSIP / Emideltide in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/dsip",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries"
    },
    {
      "recordId": "pl-canada-province-dsip-nova-scotia",
      "compound": "DSIP / Emideltide",
      "compoundSlug": "dsip",
      "compoundAliases": [
        "Delta sleep-inducing peptide",
        "Emideltide",
        "DSIP nonapeptide",
        "delta sleep-inducing peptide",
        "delta sleep inducing peptide",
        "DSIP peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "FDA-flagged unapproved research-market peptide identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "DSIP / Emideltide in Nova Scotia",
      "boundedAnswer": "DSIP / Emideltide in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/dsip",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries"
    },
    {
      "recordId": "pl-canada-province-dsip-ontario",
      "compound": "DSIP / Emideltide",
      "compoundSlug": "dsip",
      "compoundAliases": [
        "Delta sleep-inducing peptide",
        "Emideltide",
        "DSIP nonapeptide",
        "delta sleep-inducing peptide",
        "delta sleep inducing peptide",
        "DSIP peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "FDA-flagged unapproved research-market peptide identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "DSIP / Emideltide in Ontario",
      "boundedAnswer": "DSIP / Emideltide in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/dsip",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries"
    },
    {
      "recordId": "pl-canada-province-dsip-prince-edward-island",
      "compound": "DSIP / Emideltide",
      "compoundSlug": "dsip",
      "compoundAliases": [
        "Delta sleep-inducing peptide",
        "Emideltide",
        "DSIP nonapeptide",
        "delta sleep-inducing peptide",
        "delta sleep inducing peptide",
        "DSIP peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "FDA-flagged unapproved research-market peptide identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "DSIP / Emideltide in Prince Edward Island",
      "boundedAnswer": "DSIP / Emideltide in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/dsip",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries"
    },
    {
      "recordId": "pl-canada-province-dsip-quebec",
      "compound": "DSIP / Emideltide",
      "compoundSlug": "dsip",
      "compoundAliases": [
        "Delta sleep-inducing peptide",
        "Emideltide",
        "DSIP nonapeptide",
        "delta sleep-inducing peptide",
        "delta sleep inducing peptide",
        "DSIP peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "FDA-flagged unapproved research-market peptide identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "DSIP / Emideltide in Quebec",
      "boundedAnswer": "DSIP / Emideltide in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/dsip",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries"
    },
    {
      "recordId": "pl-canada-province-dsip-saskatchewan",
      "compound": "DSIP / Emideltide",
      "compoundSlug": "dsip",
      "compoundAliases": [
        "Delta sleep-inducing peptide",
        "Emideltide",
        "DSIP nonapeptide",
        "delta sleep-inducing peptide",
        "delta sleep inducing peptide",
        "DSIP peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "FDA-flagged unapproved research-market peptide identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "DSIP / Emideltide in Saskatchewan",
      "boundedAnswer": "DSIP / Emideltide in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/dsip",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries"
    },
    {
      "recordId": "pl-canada-province-igf-1-lr3-alberta",
      "compound": "IGF-1 LR3",
      "compoundSlug": "igf-1-lr3",
      "compoundAliases": [
        "Long R3 IGF-1",
        "Insulin-like growth factor long chain R3",
        "100 mcg IGF-1 LR3",
        "IGF1 LR3",
        "IGF-1 long R3"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "IGF-1 LR3 in Alberta",
      "boundedAnswer": "IGF-1 LR3 in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3",
      "identitySourceLabel": "Read the PubChem substance record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries"
    },
    {
      "recordId": "pl-canada-province-igf-1-lr3-british-columbia",
      "compound": "IGF-1 LR3",
      "compoundSlug": "igf-1-lr3",
      "compoundAliases": [
        "Long R3 IGF-1",
        "Insulin-like growth factor long chain R3",
        "100 mcg IGF-1 LR3",
        "IGF1 LR3",
        "IGF-1 long R3"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "IGF-1 LR3 in British Columbia",
      "boundedAnswer": "IGF-1 LR3 in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3",
      "identitySourceLabel": "Read the PubChem substance record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries"
    },
    {
      "recordId": "pl-canada-province-igf-1-lr3-manitoba",
      "compound": "IGF-1 LR3",
      "compoundSlug": "igf-1-lr3",
      "compoundAliases": [
        "Long R3 IGF-1",
        "Insulin-like growth factor long chain R3",
        "100 mcg IGF-1 LR3",
        "IGF1 LR3",
        "IGF-1 long R3"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "IGF-1 LR3 in Manitoba",
      "boundedAnswer": "IGF-1 LR3 in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3",
      "identitySourceLabel": "Read the PubChem substance record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries"
    },
    {
      "recordId": "pl-canada-province-igf-1-lr3-new-brunswick",
      "compound": "IGF-1 LR3",
      "compoundSlug": "igf-1-lr3",
      "compoundAliases": [
        "Long R3 IGF-1",
        "Insulin-like growth factor long chain R3",
        "100 mcg IGF-1 LR3",
        "IGF1 LR3",
        "IGF-1 long R3"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "IGF-1 LR3 in New Brunswick",
      "boundedAnswer": "IGF-1 LR3 in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3",
      "identitySourceLabel": "Read the PubChem substance record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries"
    },
    {
      "recordId": "pl-canada-province-igf-1-lr3-newfoundland-and-labrador",
      "compound": "IGF-1 LR3",
      "compoundSlug": "igf-1-lr3",
      "compoundAliases": [
        "Long R3 IGF-1",
        "Insulin-like growth factor long chain R3",
        "100 mcg IGF-1 LR3",
        "IGF1 LR3",
        "IGF-1 long R3"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "IGF-1 LR3 in Newfoundland and Labrador",
      "boundedAnswer": "IGF-1 LR3 in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3",
      "identitySourceLabel": "Read the PubChem substance record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries"
    },
    {
      "recordId": "pl-canada-province-igf-1-lr3-nova-scotia",
      "compound": "IGF-1 LR3",
      "compoundSlug": "igf-1-lr3",
      "compoundAliases": [
        "Long R3 IGF-1",
        "Insulin-like growth factor long chain R3",
        "100 mcg IGF-1 LR3",
        "IGF1 LR3",
        "IGF-1 long R3"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "IGF-1 LR3 in Nova Scotia",
      "boundedAnswer": "IGF-1 LR3 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3",
      "identitySourceLabel": "Read the PubChem substance record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries"
    },
    {
      "recordId": "pl-canada-province-igf-1-lr3-ontario",
      "compound": "IGF-1 LR3",
      "compoundSlug": "igf-1-lr3",
      "compoundAliases": [
        "Long R3 IGF-1",
        "Insulin-like growth factor long chain R3",
        "100 mcg IGF-1 LR3",
        "IGF1 LR3",
        "IGF-1 long R3"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "IGF-1 LR3 in Ontario",
      "boundedAnswer": "IGF-1 LR3 in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3",
      "identitySourceLabel": "Read the PubChem substance record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries"
    },
    {
      "recordId": "pl-canada-province-igf-1-lr3-prince-edward-island",
      "compound": "IGF-1 LR3",
      "compoundSlug": "igf-1-lr3",
      "compoundAliases": [
        "Long R3 IGF-1",
        "Insulin-like growth factor long chain R3",
        "100 mcg IGF-1 LR3",
        "IGF1 LR3",
        "IGF-1 long R3"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "IGF-1 LR3 in Prince Edward Island",
      "boundedAnswer": "IGF-1 LR3 in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3",
      "identitySourceLabel": "Read the PubChem substance record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries"
    },
    {
      "recordId": "pl-canada-province-igf-1-lr3-quebec",
      "compound": "IGF-1 LR3",
      "compoundSlug": "igf-1-lr3",
      "compoundAliases": [
        "Long R3 IGF-1",
        "Insulin-like growth factor long chain R3",
        "100 mcg IGF-1 LR3",
        "IGF1 LR3",
        "IGF-1 long R3"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "IGF-1 LR3 in Quebec",
      "boundedAnswer": "IGF-1 LR3 in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3",
      "identitySourceLabel": "Read the PubChem substance record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries"
    },
    {
      "recordId": "pl-canada-province-igf-1-lr3-saskatchewan",
      "compound": "IGF-1 LR3",
      "compoundSlug": "igf-1-lr3",
      "compoundAliases": [
        "Long R3 IGF-1",
        "Insulin-like growth factor long chain R3",
        "100 mcg IGF-1 LR3",
        "IGF1 LR3",
        "IGF-1 long R3"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "IGF-1 LR3 in Saskatchewan",
      "boundedAnswer": "IGF-1 LR3 in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3",
      "identitySourceLabel": "Read the PubChem substance record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries"
    },
    {
      "recordId": "pl-canada-province-kisspeptin-10-alberta",
      "compound": "Kisspeptin-10 / KP-10",
      "compoundSlug": "kisspeptin-10",
      "compoundAliases": [
        "Kisspeptin 10",
        "Kp-10",
        "Metastin fragment",
        "KISS1 decapeptide",
        "kisspeptin 10",
        "KP-10",
        "Kp10"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Kisspeptin-10 / KP-10 in Alberta",
      "boundedAnswer": "Kisspeptin-10 / KP-10 in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries"
    },
    {
      "recordId": "pl-canada-province-kisspeptin-10-british-columbia",
      "compound": "Kisspeptin-10 / KP-10",
      "compoundSlug": "kisspeptin-10",
      "compoundAliases": [
        "Kisspeptin 10",
        "Kp-10",
        "Metastin fragment",
        "KISS1 decapeptide",
        "kisspeptin 10",
        "KP-10",
        "Kp10"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Kisspeptin-10 / KP-10 in British Columbia",
      "boundedAnswer": "Kisspeptin-10 / KP-10 in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries"
    },
    {
      "recordId": "pl-canada-province-kisspeptin-10-manitoba",
      "compound": "Kisspeptin-10 / KP-10",
      "compoundSlug": "kisspeptin-10",
      "compoundAliases": [
        "Kisspeptin 10",
        "Kp-10",
        "Metastin fragment",
        "KISS1 decapeptide",
        "kisspeptin 10",
        "KP-10",
        "Kp10"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Kisspeptin-10 / KP-10 in Manitoba",
      "boundedAnswer": "Kisspeptin-10 / KP-10 in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries"
    },
    {
      "recordId": "pl-canada-province-kisspeptin-10-new-brunswick",
      "compound": "Kisspeptin-10 / KP-10",
      "compoundSlug": "kisspeptin-10",
      "compoundAliases": [
        "Kisspeptin 10",
        "Kp-10",
        "Metastin fragment",
        "KISS1 decapeptide",
        "kisspeptin 10",
        "KP-10",
        "Kp10"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Kisspeptin-10 / KP-10 in New Brunswick",
      "boundedAnswer": "Kisspeptin-10 / KP-10 in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries"
    },
    {
      "recordId": "pl-canada-province-kisspeptin-10-newfoundland-and-labrador",
      "compound": "Kisspeptin-10 / KP-10",
      "compoundSlug": "kisspeptin-10",
      "compoundAliases": [
        "Kisspeptin 10",
        "Kp-10",
        "Metastin fragment",
        "KISS1 decapeptide",
        "kisspeptin 10",
        "KP-10",
        "Kp10"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Kisspeptin-10 / KP-10 in Newfoundland and Labrador",
      "boundedAnswer": "Kisspeptin-10 / KP-10 in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries"
    },
    {
      "recordId": "pl-canada-province-kisspeptin-10-nova-scotia",
      "compound": "Kisspeptin-10 / KP-10",
      "compoundSlug": "kisspeptin-10",
      "compoundAliases": [
        "Kisspeptin 10",
        "Kp-10",
        "Metastin fragment",
        "KISS1 decapeptide",
        "kisspeptin 10",
        "KP-10",
        "Kp10"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Kisspeptin-10 / KP-10 in Nova Scotia",
      "boundedAnswer": "Kisspeptin-10 / KP-10 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries"
    },
    {
      "recordId": "pl-canada-province-kisspeptin-10-ontario",
      "compound": "Kisspeptin-10 / KP-10",
      "compoundSlug": "kisspeptin-10",
      "compoundAliases": [
        "Kisspeptin 10",
        "Kp-10",
        "Metastin fragment",
        "KISS1 decapeptide",
        "kisspeptin 10",
        "KP-10",
        "Kp10"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Kisspeptin-10 / KP-10 in Ontario",
      "boundedAnswer": "Kisspeptin-10 / KP-10 in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries"
    },
    {
      "recordId": "pl-canada-province-kisspeptin-10-prince-edward-island",
      "compound": "Kisspeptin-10 / KP-10",
      "compoundSlug": "kisspeptin-10",
      "compoundAliases": [
        "Kisspeptin 10",
        "Kp-10",
        "Metastin fragment",
        "KISS1 decapeptide",
        "kisspeptin 10",
        "KP-10",
        "Kp10"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Kisspeptin-10 / KP-10 in Prince Edward Island",
      "boundedAnswer": "Kisspeptin-10 / KP-10 in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries"
    },
    {
      "recordId": "pl-canada-province-kisspeptin-10-quebec",
      "compound": "Kisspeptin-10 / KP-10",
      "compoundSlug": "kisspeptin-10",
      "compoundAliases": [
        "Kisspeptin 10",
        "Kp-10",
        "Metastin fragment",
        "KISS1 decapeptide",
        "kisspeptin 10",
        "KP-10",
        "Kp10"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Kisspeptin-10 / KP-10 in Quebec",
      "boundedAnswer": "Kisspeptin-10 / KP-10 in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries"
    },
    {
      "recordId": "pl-canada-province-kisspeptin-10-saskatchewan",
      "compound": "Kisspeptin-10 / KP-10",
      "compoundSlug": "kisspeptin-10",
      "compoundAliases": [
        "Kisspeptin 10",
        "Kp-10",
        "Metastin fragment",
        "KISS1 decapeptide",
        "kisspeptin 10",
        "KP-10",
        "Kp10"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Kisspeptin-10 / KP-10 in Saskatchewan",
      "boundedAnswer": "Kisspeptin-10 / KP-10 in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-i-alberta",
      "compound": "Melanotan I",
      "compoundSlug": "melanotan-i",
      "compoundAliases": [
        "MT-I",
        "MT1",
        "Afamelanotide",
        "Melanotan 1"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity separated from SCENESSE",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Melanotan I in Alberta",
      "boundedAnswer": "Melanotan I in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i",
      "identitySourceLabel": "Read the current SCENESSE label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-i-british-columbia",
      "compound": "Melanotan I",
      "compoundSlug": "melanotan-i",
      "compoundAliases": [
        "MT-I",
        "MT1",
        "Afamelanotide",
        "Melanotan 1"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity separated from SCENESSE",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Melanotan I in British Columbia",
      "boundedAnswer": "Melanotan I in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i",
      "identitySourceLabel": "Read the current SCENESSE label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-i-manitoba",
      "compound": "Melanotan I",
      "compoundSlug": "melanotan-i",
      "compoundAliases": [
        "MT-I",
        "MT1",
        "Afamelanotide",
        "Melanotan 1"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity separated from SCENESSE",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Melanotan I in Manitoba",
      "boundedAnswer": "Melanotan I in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i",
      "identitySourceLabel": "Read the current SCENESSE label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-i-new-brunswick",
      "compound": "Melanotan I",
      "compoundSlug": "melanotan-i",
      "compoundAliases": [
        "MT-I",
        "MT1",
        "Afamelanotide",
        "Melanotan 1"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity separated from SCENESSE",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Melanotan I in New Brunswick",
      "boundedAnswer": "Melanotan I in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i",
      "identitySourceLabel": "Read the current SCENESSE label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-i-newfoundland-and-labrador",
      "compound": "Melanotan I",
      "compoundSlug": "melanotan-i",
      "compoundAliases": [
        "MT-I",
        "MT1",
        "Afamelanotide",
        "Melanotan 1"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity separated from SCENESSE",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Melanotan I in Newfoundland and Labrador",
      "boundedAnswer": "Melanotan I in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i",
      "identitySourceLabel": "Read the current SCENESSE label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-i-nova-scotia",
      "compound": "Melanotan I",
      "compoundSlug": "melanotan-i",
      "compoundAliases": [
        "MT-I",
        "MT1",
        "Afamelanotide",
        "Melanotan 1"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity separated from SCENESSE",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Melanotan I in Nova Scotia",
      "boundedAnswer": "Melanotan I in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i",
      "identitySourceLabel": "Read the current SCENESSE label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-i-ontario",
      "compound": "Melanotan I",
      "compoundSlug": "melanotan-i",
      "compoundAliases": [
        "MT-I",
        "MT1",
        "Afamelanotide",
        "Melanotan 1"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity separated from SCENESSE",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Melanotan I in Ontario",
      "boundedAnswer": "Melanotan I in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i",
      "identitySourceLabel": "Read the current SCENESSE label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-i-prince-edward-island",
      "compound": "Melanotan I",
      "compoundSlug": "melanotan-i",
      "compoundAliases": [
        "MT-I",
        "MT1",
        "Afamelanotide",
        "Melanotan 1"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity separated from SCENESSE",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Melanotan I in Prince Edward Island",
      "boundedAnswer": "Melanotan I in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i",
      "identitySourceLabel": "Read the current SCENESSE label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-i-quebec",
      "compound": "Melanotan I",
      "compoundSlug": "melanotan-i",
      "compoundAliases": [
        "MT-I",
        "MT1",
        "Afamelanotide",
        "Melanotan 1"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity separated from SCENESSE",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Melanotan I in Quebec",
      "boundedAnswer": "Melanotan I in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i",
      "identitySourceLabel": "Read the current SCENESSE label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries"
    },
    {
      "recordId": "pl-canada-province-melanotan-i-saskatchewan",
      "compound": "Melanotan I",
      "compoundSlug": "melanotan-i",
      "compoundAliases": [
        "MT-I",
        "MT1",
        "Afamelanotide",
        "Melanotan 1"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity separated from SCENESSE",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Melanotan I in Saskatchewan",
      "boundedAnswer": "Melanotan I in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i",
      "identitySourceLabel": "Read the current SCENESSE label",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries"
    },
    {
      "recordId": "pl-canada-province-nad-plus-alberta",
      "compound": "NAD+",
      "compoundSlug": "nad-plus",
      "compoundAliases": [
        "Nicotinamide adenine dinucleotide",
        "NAD plus",
        "nicotinamide adenine dinucleotide",
        "NAD peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market non-peptide coenzyme identity",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "NAD+ in Alberta",
      "boundedAnswer": "NAD+ in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/nad-plus",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries"
    },
    {
      "recordId": "pl-canada-province-nad-plus-british-columbia",
      "compound": "NAD+",
      "compoundSlug": "nad-plus",
      "compoundAliases": [
        "Nicotinamide adenine dinucleotide",
        "NAD plus",
        "nicotinamide adenine dinucleotide",
        "NAD peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market non-peptide coenzyme identity",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "NAD+ in British Columbia",
      "boundedAnswer": "NAD+ in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/nad-plus",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries"
    },
    {
      "recordId": "pl-canada-province-nad-plus-manitoba",
      "compound": "NAD+",
      "compoundSlug": "nad-plus",
      "compoundAliases": [
        "Nicotinamide adenine dinucleotide",
        "NAD plus",
        "nicotinamide adenine dinucleotide",
        "NAD peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market non-peptide coenzyme identity",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "NAD+ in Manitoba",
      "boundedAnswer": "NAD+ in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/nad-plus",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries"
    },
    {
      "recordId": "pl-canada-province-nad-plus-new-brunswick",
      "compound": "NAD+",
      "compoundSlug": "nad-plus",
      "compoundAliases": [
        "Nicotinamide adenine dinucleotide",
        "NAD plus",
        "nicotinamide adenine dinucleotide",
        "NAD peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market non-peptide coenzyme identity",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "NAD+ in New Brunswick",
      "boundedAnswer": "NAD+ in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/nad-plus",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries"
    },
    {
      "recordId": "pl-canada-province-nad-plus-newfoundland-and-labrador",
      "compound": "NAD+",
      "compoundSlug": "nad-plus",
      "compoundAliases": [
        "Nicotinamide adenine dinucleotide",
        "NAD plus",
        "nicotinamide adenine dinucleotide",
        "NAD peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market non-peptide coenzyme identity",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "NAD+ in Newfoundland and Labrador",
      "boundedAnswer": "NAD+ in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/nad-plus",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries"
    },
    {
      "recordId": "pl-canada-province-nad-plus-nova-scotia",
      "compound": "NAD+",
      "compoundSlug": "nad-plus",
      "compoundAliases": [
        "Nicotinamide adenine dinucleotide",
        "NAD plus",
        "nicotinamide adenine dinucleotide",
        "NAD peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market non-peptide coenzyme identity",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "NAD+ in Nova Scotia",
      "boundedAnswer": "NAD+ in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/nad-plus",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries"
    },
    {
      "recordId": "pl-canada-province-nad-plus-ontario",
      "compound": "NAD+",
      "compoundSlug": "nad-plus",
      "compoundAliases": [
        "Nicotinamide adenine dinucleotide",
        "NAD plus",
        "nicotinamide adenine dinucleotide",
        "NAD peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market non-peptide coenzyme identity",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "NAD+ in Ontario",
      "boundedAnswer": "NAD+ in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/nad-plus",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries"
    },
    {
      "recordId": "pl-canada-province-nad-plus-prince-edward-island",
      "compound": "NAD+",
      "compoundSlug": "nad-plus",
      "compoundAliases": [
        "Nicotinamide adenine dinucleotide",
        "NAD plus",
        "nicotinamide adenine dinucleotide",
        "NAD peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market non-peptide coenzyme identity",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "NAD+ in Prince Edward Island",
      "boundedAnswer": "NAD+ in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/nad-plus",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries"
    },
    {
      "recordId": "pl-canada-province-nad-plus-quebec",
      "compound": "NAD+",
      "compoundSlug": "nad-plus",
      "compoundAliases": [
        "Nicotinamide adenine dinucleotide",
        "NAD plus",
        "nicotinamide adenine dinucleotide",
        "NAD peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market non-peptide coenzyme identity",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "NAD+ in Quebec",
      "boundedAnswer": "NAD+ in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/nad-plus",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries"
    },
    {
      "recordId": "pl-canada-province-nad-plus-saskatchewan",
      "compound": "NAD+",
      "compoundSlug": "nad-plus",
      "compoundAliases": [
        "Nicotinamide adenine dinucleotide",
        "NAD plus",
        "nicotinamide adenine dinucleotide",
        "NAD peptide"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market non-peptide coenzyme identity",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "NAD+ in Saskatchewan",
      "boundedAnswer": "NAD+ in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/nad-plus",
      "identitySourceLabel": "Read the PubChem compound record",
      "identitySourcePublisher": "National Library of Medicine, PubChem",
      "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries"
    },
    {
      "recordId": "pl-canada-province-sermorelin-alberta",
      "compound": "Sermorelin",
      "compoundSlug": "sermorelin",
      "compoundAliases": [
        "GHRH 1-29",
        "Sermorelin acetate",
        "Geref"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a withdrawn historical medicine record",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Sermorelin in Alberta",
      "boundedAnswer": "Sermorelin in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/sermorelin",
      "identitySourceLabel": "Read the FDA orphan-drug record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries"
    },
    {
      "recordId": "pl-canada-province-sermorelin-british-columbia",
      "compound": "Sermorelin",
      "compoundSlug": "sermorelin",
      "compoundAliases": [
        "GHRH 1-29",
        "Sermorelin acetate",
        "Geref"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a withdrawn historical medicine record",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Sermorelin in British Columbia",
      "boundedAnswer": "Sermorelin in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/sermorelin",
      "identitySourceLabel": "Read the FDA orphan-drug record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries"
    },
    {
      "recordId": "pl-canada-province-sermorelin-manitoba",
      "compound": "Sermorelin",
      "compoundSlug": "sermorelin",
      "compoundAliases": [
        "GHRH 1-29",
        "Sermorelin acetate",
        "Geref"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a withdrawn historical medicine record",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Sermorelin in Manitoba",
      "boundedAnswer": "Sermorelin in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/sermorelin",
      "identitySourceLabel": "Read the FDA orphan-drug record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries"
    },
    {
      "recordId": "pl-canada-province-sermorelin-new-brunswick",
      "compound": "Sermorelin",
      "compoundSlug": "sermorelin",
      "compoundAliases": [
        "GHRH 1-29",
        "Sermorelin acetate",
        "Geref"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a withdrawn historical medicine record",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Sermorelin in New Brunswick",
      "boundedAnswer": "Sermorelin in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/sermorelin",
      "identitySourceLabel": "Read the FDA orphan-drug record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries"
    },
    {
      "recordId": "pl-canada-province-sermorelin-newfoundland-and-labrador",
      "compound": "Sermorelin",
      "compoundSlug": "sermorelin",
      "compoundAliases": [
        "GHRH 1-29",
        "Sermorelin acetate",
        "Geref"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a withdrawn historical medicine record",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Sermorelin in Newfoundland and Labrador",
      "boundedAnswer": "Sermorelin in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/sermorelin",
      "identitySourceLabel": "Read the FDA orphan-drug record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries"
    },
    {
      "recordId": "pl-canada-province-sermorelin-nova-scotia",
      "compound": "Sermorelin",
      "compoundSlug": "sermorelin",
      "compoundAliases": [
        "GHRH 1-29",
        "Sermorelin acetate",
        "Geref"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a withdrawn historical medicine record",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Sermorelin in Nova Scotia",
      "boundedAnswer": "Sermorelin in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/sermorelin",
      "identitySourceLabel": "Read the FDA orphan-drug record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries"
    },
    {
      "recordId": "pl-canada-province-sermorelin-ontario",
      "compound": "Sermorelin",
      "compoundSlug": "sermorelin",
      "compoundAliases": [
        "GHRH 1-29",
        "Sermorelin acetate",
        "Geref"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a withdrawn historical medicine record",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Sermorelin in Ontario",
      "boundedAnswer": "Sermorelin in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/sermorelin",
      "identitySourceLabel": "Read the FDA orphan-drug record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries"
    },
    {
      "recordId": "pl-canada-province-sermorelin-prince-edward-island",
      "compound": "Sermorelin",
      "compoundSlug": "sermorelin",
      "compoundAliases": [
        "GHRH 1-29",
        "Sermorelin acetate",
        "Geref"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a withdrawn historical medicine record",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Sermorelin in Prince Edward Island",
      "boundedAnswer": "Sermorelin in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/sermorelin",
      "identitySourceLabel": "Read the FDA orphan-drug record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries"
    },
    {
      "recordId": "pl-canada-province-sermorelin-quebec",
      "compound": "Sermorelin",
      "compoundSlug": "sermorelin",
      "compoundAliases": [
        "GHRH 1-29",
        "Sermorelin acetate",
        "Geref"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a withdrawn historical medicine record",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Sermorelin in Quebec",
      "boundedAnswer": "Sermorelin in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/sermorelin",
      "identitySourceLabel": "Read the FDA orphan-drug record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries"
    },
    {
      "recordId": "pl-canada-province-sermorelin-saskatchewan",
      "compound": "Sermorelin",
      "compoundSlug": "sermorelin",
      "compoundAliases": [
        "GHRH 1-29",
        "Sermorelin acetate",
        "Geref"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "US research-market identity with a withdrawn historical medicine record",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Sermorelin in Saskatchewan",
      "boundedAnswer": "Sermorelin in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/sermorelin",
      "identitySourceLabel": "Read the FDA orphan-drug record",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries"
    },
    {
      "recordId": "pl-canada-province-thymosin-alpha-1-alberta",
      "compound": "Thymosin Alpha-1",
      "compoundSlug": "thymosin-alpha-1",
      "compoundAliases": [
        "Thymalfasin",
        "TA1",
        "Thymosin alpha 1",
        "thymosin alpha 1",
        "TA-1",
        "Tα1",
        "thymalfasin"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "No FDA-approved US product; exact foreign prescription products exist",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Thymosin Alpha-1 in Alberta",
      "boundedAnswer": "Thymosin Alpha-1 in Alberta begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries"
    },
    {
      "recordId": "pl-canada-province-thymosin-alpha-1-british-columbia",
      "compound": "Thymosin Alpha-1",
      "compoundSlug": "thymosin-alpha-1",
      "compoundAliases": [
        "Thymalfasin",
        "TA1",
        "Thymosin alpha 1",
        "thymosin alpha 1",
        "TA-1",
        "Tα1",
        "thymalfasin"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "No FDA-approved US product; exact foreign prescription products exist",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Thymosin Alpha-1 in British Columbia",
      "boundedAnswer": "Thymosin Alpha-1 in British Columbia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries"
    },
    {
      "recordId": "pl-canada-province-thymosin-alpha-1-manitoba",
      "compound": "Thymosin Alpha-1",
      "compoundSlug": "thymosin-alpha-1",
      "compoundAliases": [
        "Thymalfasin",
        "TA1",
        "Thymosin alpha 1",
        "thymosin alpha 1",
        "TA-1",
        "Tα1",
        "thymalfasin"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "No FDA-approved US product; exact foreign prescription products exist",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Thymosin Alpha-1 in Manitoba",
      "boundedAnswer": "Thymosin Alpha-1 in Manitoba begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries"
    },
    {
      "recordId": "pl-canada-province-thymosin-alpha-1-new-brunswick",
      "compound": "Thymosin Alpha-1",
      "compoundSlug": "thymosin-alpha-1",
      "compoundAliases": [
        "Thymalfasin",
        "TA1",
        "Thymosin alpha 1",
        "thymosin alpha 1",
        "TA-1",
        "Tα1",
        "thymalfasin"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "No FDA-approved US product; exact foreign prescription products exist",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Thymosin Alpha-1 in New Brunswick",
      "boundedAnswer": "Thymosin Alpha-1 in New Brunswick begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries"
    },
    {
      "recordId": "pl-canada-province-thymosin-alpha-1-newfoundland-and-labrador",
      "compound": "Thymosin Alpha-1",
      "compoundSlug": "thymosin-alpha-1",
      "compoundAliases": [
        "Thymalfasin",
        "TA1",
        "Thymosin alpha 1",
        "thymosin alpha 1",
        "TA-1",
        "Tα1",
        "thymalfasin"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "No FDA-approved US product; exact foreign prescription products exist",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Thymosin Alpha-1 in Newfoundland and Labrador",
      "boundedAnswer": "Thymosin Alpha-1 in Newfoundland and Labrador begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries"
    },
    {
      "recordId": "pl-canada-province-thymosin-alpha-1-nova-scotia",
      "compound": "Thymosin Alpha-1",
      "compoundSlug": "thymosin-alpha-1",
      "compoundAliases": [
        "Thymalfasin",
        "TA1",
        "Thymosin alpha 1",
        "thymosin alpha 1",
        "TA-1",
        "Tα1",
        "thymalfasin"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "No FDA-approved US product; exact foreign prescription products exist",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Thymosin Alpha-1 in Nova Scotia",
      "boundedAnswer": "Thymosin Alpha-1 in Nova Scotia begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries"
    },
    {
      "recordId": "pl-canada-province-thymosin-alpha-1-ontario",
      "compound": "Thymosin Alpha-1",
      "compoundSlug": "thymosin-alpha-1",
      "compoundAliases": [
        "Thymalfasin",
        "TA1",
        "Thymosin alpha 1",
        "thymosin alpha 1",
        "TA-1",
        "Tα1",
        "thymalfasin"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "No FDA-approved US product; exact foreign prescription products exist",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Thymosin Alpha-1 in Ontario",
      "boundedAnswer": "Thymosin Alpha-1 in Ontario begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries"
    },
    {
      "recordId": "pl-canada-province-thymosin-alpha-1-prince-edward-island",
      "compound": "Thymosin Alpha-1",
      "compoundSlug": "thymosin-alpha-1",
      "compoundAliases": [
        "Thymalfasin",
        "TA1",
        "Thymosin alpha 1",
        "thymosin alpha 1",
        "TA-1",
        "Tα1",
        "thymalfasin"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "No FDA-approved US product; exact foreign prescription products exist",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Thymosin Alpha-1 in Prince Edward Island",
      "boundedAnswer": "Thymosin Alpha-1 in Prince Edward Island begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries"
    },
    {
      "recordId": "pl-canada-province-thymosin-alpha-1-quebec",
      "compound": "Thymosin Alpha-1",
      "compoundSlug": "thymosin-alpha-1",
      "compoundAliases": [
        "Thymalfasin",
        "TA1",
        "Thymosin alpha 1",
        "thymosin alpha 1",
        "TA-1",
        "Tα1",
        "thymalfasin"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "No FDA-approved US product; exact foreign prescription products exist",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Thymosin Alpha-1 in Quebec",
      "boundedAnswer": "Thymosin Alpha-1 in Quebec begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries"
    },
    {
      "recordId": "pl-canada-province-thymosin-alpha-1-saskatchewan",
      "compound": "Thymosin Alpha-1",
      "compoundSlug": "thymosin-alpha-1",
      "compoundAliases": [
        "Thymalfasin",
        "TA1",
        "Thymosin alpha 1",
        "thymosin alpha 1",
        "TA-1",
        "Tα1",
        "thymalfasin"
      ],
      "evidenceLane": "Research price board",
      "identityStatus": "No FDA-approved US product; exact foreign prescription products exist",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Thymosin Alpha-1 in Saskatchewan",
      "boundedAnswer": "Thymosin Alpha-1 in Saskatchewan begins with a research-market identity, not a finding that a same-name product is authorized, available, lawfully supplied, or appropriate for use in Canada. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1",
      "identitySourceLabel": "Read the FDA source",
      "identitySourcePublisher": "U.S. Food and Drug Administration",
      "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries"
    },
    {
      "recordId": "pl-canada-province-egrifta-wr-alberta",
      "compound": "EGRIFTA WR",
      "compoundSlug": "egrifta-wr",
      "compoundAliases": [
        "tesamorelin",
        "Egrifta WR",
        "Egrifta SV",
        "TH9507",
        "BLA 022505",
        "GHRF analog",
        "Egrifta",
        "tesamorelin medicine"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with a withdrawn EU application",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "EGRIFTA WR in Alberta",
      "boundedAnswer": "EGRIFTA WR in Alberta begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr",
      "identitySourceLabel": "Current EGRIFTA WR prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries"
    },
    {
      "recordId": "pl-canada-province-egrifta-wr-british-columbia",
      "compound": "EGRIFTA WR",
      "compoundSlug": "egrifta-wr",
      "compoundAliases": [
        "tesamorelin",
        "Egrifta WR",
        "Egrifta SV",
        "TH9507",
        "BLA 022505",
        "GHRF analog",
        "Egrifta",
        "tesamorelin medicine"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with a withdrawn EU application",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "EGRIFTA WR in British Columbia",
      "boundedAnswer": "EGRIFTA WR in British Columbia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr",
      "identitySourceLabel": "Current EGRIFTA WR prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries"
    },
    {
      "recordId": "pl-canada-province-egrifta-wr-manitoba",
      "compound": "EGRIFTA WR",
      "compoundSlug": "egrifta-wr",
      "compoundAliases": [
        "tesamorelin",
        "Egrifta WR",
        "Egrifta SV",
        "TH9507",
        "BLA 022505",
        "GHRF analog",
        "Egrifta",
        "tesamorelin medicine"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with a withdrawn EU application",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "EGRIFTA WR in Manitoba",
      "boundedAnswer": "EGRIFTA WR in Manitoba begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr",
      "identitySourceLabel": "Current EGRIFTA WR prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries"
    },
    {
      "recordId": "pl-canada-province-egrifta-wr-new-brunswick",
      "compound": "EGRIFTA WR",
      "compoundSlug": "egrifta-wr",
      "compoundAliases": [
        "tesamorelin",
        "Egrifta WR",
        "Egrifta SV",
        "TH9507",
        "BLA 022505",
        "GHRF analog",
        "Egrifta",
        "tesamorelin medicine"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with a withdrawn EU application",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "EGRIFTA WR in New Brunswick",
      "boundedAnswer": "EGRIFTA WR in New Brunswick begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr",
      "identitySourceLabel": "Current EGRIFTA WR prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries"
    },
    {
      "recordId": "pl-canada-province-egrifta-wr-newfoundland-and-labrador",
      "compound": "EGRIFTA WR",
      "compoundSlug": "egrifta-wr",
      "compoundAliases": [
        "tesamorelin",
        "Egrifta WR",
        "Egrifta SV",
        "TH9507",
        "BLA 022505",
        "GHRF analog",
        "Egrifta",
        "tesamorelin medicine"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with a withdrawn EU application",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "EGRIFTA WR in Newfoundland and Labrador",
      "boundedAnswer": "EGRIFTA WR in Newfoundland and Labrador begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr",
      "identitySourceLabel": "Current EGRIFTA WR prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries"
    },
    {
      "recordId": "pl-canada-province-egrifta-wr-nova-scotia",
      "compound": "EGRIFTA WR",
      "compoundSlug": "egrifta-wr",
      "compoundAliases": [
        "tesamorelin",
        "Egrifta WR",
        "Egrifta SV",
        "TH9507",
        "BLA 022505",
        "GHRF analog",
        "Egrifta",
        "tesamorelin medicine"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with a withdrawn EU application",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "EGRIFTA WR in Nova Scotia",
      "boundedAnswer": "EGRIFTA WR in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr",
      "identitySourceLabel": "Current EGRIFTA WR prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries"
    },
    {
      "recordId": "pl-canada-province-egrifta-wr-ontario",
      "compound": "EGRIFTA WR",
      "compoundSlug": "egrifta-wr",
      "compoundAliases": [
        "tesamorelin",
        "Egrifta WR",
        "Egrifta SV",
        "TH9507",
        "BLA 022505",
        "GHRF analog",
        "Egrifta",
        "tesamorelin medicine"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with a withdrawn EU application",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "EGRIFTA WR in Ontario",
      "boundedAnswer": "EGRIFTA WR in Ontario begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr",
      "identitySourceLabel": "Current EGRIFTA WR prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries"
    },
    {
      "recordId": "pl-canada-province-egrifta-wr-prince-edward-island",
      "compound": "EGRIFTA WR",
      "compoundSlug": "egrifta-wr",
      "compoundAliases": [
        "tesamorelin",
        "Egrifta WR",
        "Egrifta SV",
        "TH9507",
        "BLA 022505",
        "GHRF analog",
        "Egrifta",
        "tesamorelin medicine"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with a withdrawn EU application",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "EGRIFTA WR in Prince Edward Island",
      "boundedAnswer": "EGRIFTA WR in Prince Edward Island begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr",
      "identitySourceLabel": "Current EGRIFTA WR prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries"
    },
    {
      "recordId": "pl-canada-province-egrifta-wr-quebec",
      "compound": "EGRIFTA WR",
      "compoundSlug": "egrifta-wr",
      "compoundAliases": [
        "tesamorelin",
        "Egrifta WR",
        "Egrifta SV",
        "TH9507",
        "BLA 022505",
        "GHRF analog",
        "Egrifta",
        "tesamorelin medicine"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with a withdrawn EU application",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "EGRIFTA WR in Quebec",
      "boundedAnswer": "EGRIFTA WR in Quebec begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr",
      "identitySourceLabel": "Current EGRIFTA WR prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries"
    },
    {
      "recordId": "pl-canada-province-egrifta-wr-saskatchewan",
      "compound": "EGRIFTA WR",
      "compoundSlug": "egrifta-wr",
      "compoundAliases": [
        "tesamorelin",
        "Egrifta WR",
        "Egrifta SV",
        "TH9507",
        "BLA 022505",
        "GHRF analog",
        "Egrifta",
        "tesamorelin medicine"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "FDA-approved US medicine with a withdrawn EU application",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "EGRIFTA WR in Saskatchewan",
      "boundedAnswer": "EGRIFTA WR in Saskatchewan begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr",
      "identitySourceLabel": "Current EGRIFTA WR prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries"
    },
    {
      "recordId": "pl-canada-province-liraglutide-alberta",
      "compound": "Liraglutide",
      "compoundSlug": "liraglutide",
      "compoundAliases": [
        "liraglutide",
        "Saxenda",
        "NN2211",
        "NDA 206321",
        "GLP-1 receptor agonist",
        "Saxenda by country",
        "liraglutida",
        "Liraglutid"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "Liraglutide in Alberta",
      "boundedAnswer": "Liraglutide in Alberta begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda",
      "identitySourceLabel": "Current SAXENDA prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries"
    },
    {
      "recordId": "pl-canada-province-liraglutide-british-columbia",
      "compound": "Liraglutide",
      "compoundSlug": "liraglutide",
      "compoundAliases": [
        "liraglutide",
        "Saxenda",
        "NN2211",
        "NDA 206321",
        "GLP-1 receptor agonist",
        "Saxenda by country",
        "liraglutida",
        "Liraglutid"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "Liraglutide in British Columbia",
      "boundedAnswer": "Liraglutide in British Columbia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda",
      "identitySourceLabel": "Current SAXENDA prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries"
    },
    {
      "recordId": "pl-canada-province-liraglutide-manitoba",
      "compound": "Liraglutide",
      "compoundSlug": "liraglutide",
      "compoundAliases": [
        "liraglutide",
        "Saxenda",
        "NN2211",
        "NDA 206321",
        "GLP-1 receptor agonist",
        "Saxenda by country",
        "liraglutida",
        "Liraglutid"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "Liraglutide in Manitoba",
      "boundedAnswer": "Liraglutide in Manitoba begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda",
      "identitySourceLabel": "Current SAXENDA prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries"
    },
    {
      "recordId": "pl-canada-province-liraglutide-new-brunswick",
      "compound": "Liraglutide",
      "compoundSlug": "liraglutide",
      "compoundAliases": [
        "liraglutide",
        "Saxenda",
        "NN2211",
        "NDA 206321",
        "GLP-1 receptor agonist",
        "Saxenda by country",
        "liraglutida",
        "Liraglutid"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "Liraglutide in New Brunswick",
      "boundedAnswer": "Liraglutide in New Brunswick begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda",
      "identitySourceLabel": "Current SAXENDA prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries"
    },
    {
      "recordId": "pl-canada-province-liraglutide-newfoundland-and-labrador",
      "compound": "Liraglutide",
      "compoundSlug": "liraglutide",
      "compoundAliases": [
        "liraglutide",
        "Saxenda",
        "NN2211",
        "NDA 206321",
        "GLP-1 receptor agonist",
        "Saxenda by country",
        "liraglutida",
        "Liraglutid"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "Liraglutide in Newfoundland and Labrador",
      "boundedAnswer": "Liraglutide in Newfoundland and Labrador begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda",
      "identitySourceLabel": "Current SAXENDA prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries"
    },
    {
      "recordId": "pl-canada-province-liraglutide-nova-scotia",
      "compound": "Liraglutide",
      "compoundSlug": "liraglutide",
      "compoundAliases": [
        "liraglutide",
        "Saxenda",
        "NN2211",
        "NDA 206321",
        "GLP-1 receptor agonist",
        "Saxenda by country",
        "liraglutida",
        "Liraglutid"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "Liraglutide in Nova Scotia",
      "boundedAnswer": "Liraglutide in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda",
      "identitySourceLabel": "Current SAXENDA prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries"
    },
    {
      "recordId": "pl-canada-province-liraglutide-ontario",
      "compound": "Liraglutide",
      "compoundSlug": "liraglutide",
      "compoundAliases": [
        "liraglutide",
        "Saxenda",
        "NN2211",
        "NDA 206321",
        "GLP-1 receptor agonist",
        "Saxenda by country",
        "liraglutida",
        "Liraglutid"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "Liraglutide in Ontario",
      "boundedAnswer": "Liraglutide in Ontario begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda",
      "identitySourceLabel": "Current SAXENDA prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries"
    },
    {
      "recordId": "pl-canada-province-liraglutide-prince-edward-island",
      "compound": "Liraglutide",
      "compoundSlug": "liraglutide",
      "compoundAliases": [
        "liraglutide",
        "Saxenda",
        "NN2211",
        "NDA 206321",
        "GLP-1 receptor agonist",
        "Saxenda by country",
        "liraglutida",
        "Liraglutid"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "Liraglutide in Prince Edward Island",
      "boundedAnswer": "Liraglutide in Prince Edward Island begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda",
      "identitySourceLabel": "Current SAXENDA prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries"
    },
    {
      "recordId": "pl-canada-province-liraglutide-quebec",
      "compound": "Liraglutide",
      "compoundSlug": "liraglutide",
      "compoundAliases": [
        "liraglutide",
        "Saxenda",
        "NN2211",
        "NDA 206321",
        "GLP-1 receptor agonist",
        "Saxenda by country",
        "liraglutida",
        "Liraglutid"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "Liraglutide in Quebec",
      "boundedAnswer": "Liraglutide in Quebec begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda",
      "identitySourceLabel": "Current SAXENDA prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries"
    },
    {
      "recordId": "pl-canada-province-liraglutide-saskatchewan",
      "compound": "Liraglutide",
      "compoundSlug": "liraglutide",
      "compoundAliases": [
        "liraglutide",
        "Saxenda",
        "NN2211",
        "NDA 206321",
        "GLP-1 receptor agonist",
        "Saxenda by country",
        "liraglutida",
        "Liraglutid"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "Liraglutide in Saskatchewan",
      "boundedAnswer": "Liraglutide in Saskatchewan begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda",
      "identitySourceLabel": "Current SAXENDA prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries"
    },
    {
      "recordId": "pl-canada-province-scenesse-alberta",
      "compound": "SCENESSE",
      "compoundSlug": "scenesse",
      "compoundAliases": [
        "afamelanotide",
        "Scenesse",
        "CUV1647",
        "NDA 210797",
        "alpha-MSH analog",
        "Scenesse by country",
        "afamelanotide implant",
        "afamelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "SCENESSE in Alberta",
      "boundedAnswer": "SCENESSE in Alberta begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse",
      "identitySourceLabel": "Current SCENESSE prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries"
    },
    {
      "recordId": "pl-canada-province-scenesse-british-columbia",
      "compound": "SCENESSE",
      "compoundSlug": "scenesse",
      "compoundAliases": [
        "afamelanotide",
        "Scenesse",
        "CUV1647",
        "NDA 210797",
        "alpha-MSH analog",
        "Scenesse by country",
        "afamelanotide implant",
        "afamelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "SCENESSE in British Columbia",
      "boundedAnswer": "SCENESSE in British Columbia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse",
      "identitySourceLabel": "Current SCENESSE prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries"
    },
    {
      "recordId": "pl-canada-province-scenesse-manitoba",
      "compound": "SCENESSE",
      "compoundSlug": "scenesse",
      "compoundAliases": [
        "afamelanotide",
        "Scenesse",
        "CUV1647",
        "NDA 210797",
        "alpha-MSH analog",
        "Scenesse by country",
        "afamelanotide implant",
        "afamelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "SCENESSE in Manitoba",
      "boundedAnswer": "SCENESSE in Manitoba begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse",
      "identitySourceLabel": "Current SCENESSE prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries"
    },
    {
      "recordId": "pl-canada-province-scenesse-new-brunswick",
      "compound": "SCENESSE",
      "compoundSlug": "scenesse",
      "compoundAliases": [
        "afamelanotide",
        "Scenesse",
        "CUV1647",
        "NDA 210797",
        "alpha-MSH analog",
        "Scenesse by country",
        "afamelanotide implant",
        "afamelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "SCENESSE in New Brunswick",
      "boundedAnswer": "SCENESSE in New Brunswick begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse",
      "identitySourceLabel": "Current SCENESSE prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries"
    },
    {
      "recordId": "pl-canada-province-scenesse-newfoundland-and-labrador",
      "compound": "SCENESSE",
      "compoundSlug": "scenesse",
      "compoundAliases": [
        "afamelanotide",
        "Scenesse",
        "CUV1647",
        "NDA 210797",
        "alpha-MSH analog",
        "Scenesse by country",
        "afamelanotide implant",
        "afamelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "SCENESSE in Newfoundland and Labrador",
      "boundedAnswer": "SCENESSE in Newfoundland and Labrador begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse",
      "identitySourceLabel": "Current SCENESSE prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries"
    },
    {
      "recordId": "pl-canada-province-scenesse-nova-scotia",
      "compound": "SCENESSE",
      "compoundSlug": "scenesse",
      "compoundAliases": [
        "afamelanotide",
        "Scenesse",
        "CUV1647",
        "NDA 210797",
        "alpha-MSH analog",
        "Scenesse by country",
        "afamelanotide implant",
        "afamelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "SCENESSE in Nova Scotia",
      "boundedAnswer": "SCENESSE in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse",
      "identitySourceLabel": "Current SCENESSE prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries"
    },
    {
      "recordId": "pl-canada-province-scenesse-ontario",
      "compound": "SCENESSE",
      "compoundSlug": "scenesse",
      "compoundAliases": [
        "afamelanotide",
        "Scenesse",
        "CUV1647",
        "NDA 210797",
        "alpha-MSH analog",
        "Scenesse by country",
        "afamelanotide implant",
        "afamelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "SCENESSE in Ontario",
      "boundedAnswer": "SCENESSE in Ontario begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse",
      "identitySourceLabel": "Current SCENESSE prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries"
    },
    {
      "recordId": "pl-canada-province-scenesse-prince-edward-island",
      "compound": "SCENESSE",
      "compoundSlug": "scenesse",
      "compoundAliases": [
        "afamelanotide",
        "Scenesse",
        "CUV1647",
        "NDA 210797",
        "alpha-MSH analog",
        "Scenesse by country",
        "afamelanotide implant",
        "afamelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "SCENESSE in Prince Edward Island",
      "boundedAnswer": "SCENESSE in Prince Edward Island begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse",
      "identitySourceLabel": "Current SCENESSE prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries"
    },
    {
      "recordId": "pl-canada-province-scenesse-quebec",
      "compound": "SCENESSE",
      "compoundSlug": "scenesse",
      "compoundAliases": [
        "afamelanotide",
        "Scenesse",
        "CUV1647",
        "NDA 210797",
        "alpha-MSH analog",
        "Scenesse by country",
        "afamelanotide implant",
        "afamelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "SCENESSE in Quebec",
      "boundedAnswer": "SCENESSE in Quebec begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse",
      "identitySourceLabel": "Current SCENESSE prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries"
    },
    {
      "recordId": "pl-canada-province-scenesse-saskatchewan",
      "compound": "SCENESSE",
      "compoundSlug": "scenesse",
      "compoundAliases": [
        "afamelanotide",
        "Scenesse",
        "CUV1647",
        "NDA 210797",
        "alpha-MSH analog",
        "Scenesse by country",
        "afamelanotide implant",
        "afamelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA and EU medicine records",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "SCENESSE in Saskatchewan",
      "boundedAnswer": "SCENESSE in Saskatchewan begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse",
      "identitySourceLabel": "Current SCENESSE prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries"
    },
    {
      "recordId": "pl-canada-province-vyleesi-alberta",
      "compound": "VYLEESI",
      "compoundSlug": "vyleesi",
      "compoundAliases": [
        "bremelanotide",
        "Vyleesi",
        "PT-141",
        "NDA 210557",
        "melanocortin receptor agonist",
        "Vyleesi by country",
        "bremelanotide medicine",
        "bremelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA-approved US medicine record",
      "province": "Alberta",
      "provinceSlug": "alberta",
      "searchQuery": "VYLEESI in Alberta",
      "boundedAnswer": "VYLEESI in Alberta begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Alberta, open Find a pharmacy or pharmacy professional from Alberta College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi",
      "identitySourceLabel": "Current VYLEESI prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Alberta College of Pharmacy",
      "provinceRecordUrl": "https://abpharmacy.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/canada-provinces#alberta",
      "provinceGuideUrl": "https://peptidelocal.com/locations/alberta",
      "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries"
    },
    {
      "recordId": "pl-canada-province-vyleesi-british-columbia",
      "compound": "VYLEESI",
      "compoundSlug": "vyleesi",
      "compoundAliases": [
        "bremelanotide",
        "Vyleesi",
        "PT-141",
        "NDA 210557",
        "melanocortin receptor agonist",
        "Vyleesi by country",
        "bremelanotide medicine",
        "bremelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA-approved US medicine record",
      "province": "British Columbia",
      "provinceSlug": "british-columbia",
      "searchQuery": "VYLEESI in British Columbia",
      "boundedAnswer": "VYLEESI in British Columbia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving British Columbia, open Find a pharmacy or licensee from College of Pharmacists of British Columbia and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi",
      "identitySourceLabel": "Current VYLEESI prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or licensee",
      "provinceRecordPublisher": "College of Pharmacists of British Columbia",
      "provinceRecordUrl": "https://www.bcpharmacists.org/search-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/canada-provinces#british-columbia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/british-columbia",
      "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries"
    },
    {
      "recordId": "pl-canada-province-vyleesi-manitoba",
      "compound": "VYLEESI",
      "compoundSlug": "vyleesi",
      "compoundAliases": [
        "bremelanotide",
        "Vyleesi",
        "PT-141",
        "NDA 210557",
        "melanocortin receptor agonist",
        "Vyleesi by country",
        "bremelanotide medicine",
        "bremelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA-approved US medicine record",
      "province": "Manitoba",
      "provinceSlug": "manitoba",
      "searchQuery": "VYLEESI in Manitoba",
      "boundedAnswer": "VYLEESI in Manitoba begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Manitoba, open Find a pharmacy or pharmacy professional from College of Pharmacists of Manitoba and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi",
      "identitySourceLabel": "Current VYLEESI prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "College of Pharmacists of Manitoba",
      "provinceRecordUrl": "https://cphm.ca/protecting-the-public/find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/canada-provinces#manitoba",
      "provinceGuideUrl": "https://peptidelocal.com/locations/manitoba",
      "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries"
    },
    {
      "recordId": "pl-canada-province-vyleesi-new-brunswick",
      "compound": "VYLEESI",
      "compoundSlug": "vyleesi",
      "compoundAliases": [
        "bremelanotide",
        "Vyleesi",
        "PT-141",
        "NDA 210557",
        "melanocortin receptor agonist",
        "Vyleesi by country",
        "bremelanotide medicine",
        "bremelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA-approved US medicine record",
      "province": "New Brunswick",
      "provinceSlug": "new-brunswick",
      "searchQuery": "VYLEESI in New Brunswick",
      "boundedAnswer": "VYLEESI in New Brunswick begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving New Brunswick, open Registration and pharmacy standards route from New Brunswick College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi",
      "identitySourceLabel": "Current VYLEESI prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Registration and pharmacy standards route",
      "provinceRecordPublisher": "New Brunswick College of Pharmacists",
      "provinceRecordUrl": "https://nbpharmacists.ca/en/registration/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/canada-provinces#new-brunswick",
      "provinceGuideUrl": "https://peptidelocal.com/locations/new-brunswick",
      "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries"
    },
    {
      "recordId": "pl-canada-province-vyleesi-newfoundland-and-labrador",
      "compound": "VYLEESI",
      "compoundSlug": "vyleesi",
      "compoundAliases": [
        "bremelanotide",
        "Vyleesi",
        "PT-141",
        "NDA 210557",
        "melanocortin receptor agonist",
        "Vyleesi by country",
        "bremelanotide medicine",
        "bremelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA-approved US medicine record",
      "province": "Newfoundland and Labrador",
      "provinceSlug": "newfoundland-and-labrador",
      "searchQuery": "VYLEESI in Newfoundland and Labrador",
      "boundedAnswer": "VYLEESI in Newfoundland and Labrador begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Newfoundland and Labrador, open Find a pharmacy or professional from College of Pharmacy of Newfoundland and Labrador and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi",
      "identitySourceLabel": "Current VYLEESI prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or professional",
      "provinceRecordPublisher": "College of Pharmacy of Newfoundland and Labrador",
      "provinceRecordUrl": "https://cpnl.portalca.thentiacloud.net/webs/portal/register/#/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/canada-provinces#newfoundland-and-labrador",
      "provinceGuideUrl": "https://peptidelocal.com/locations/newfoundland-and-labrador",
      "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries"
    },
    {
      "recordId": "pl-canada-province-vyleesi-nova-scotia",
      "compound": "VYLEESI",
      "compoundSlug": "vyleesi",
      "compoundAliases": [
        "bremelanotide",
        "Vyleesi",
        "PT-141",
        "NDA 210557",
        "melanocortin receptor agonist",
        "Vyleesi by country",
        "bremelanotide medicine",
        "bremelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA-approved US medicine record",
      "province": "Nova Scotia",
      "provinceSlug": "nova-scotia",
      "searchQuery": "VYLEESI in Nova Scotia",
      "boundedAnswer": "VYLEESI in Nova Scotia begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Nova Scotia, open Find a practitioner or pharmacy from Nova Scotia Pharmacy Regulator and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi",
      "identitySourceLabel": "Current VYLEESI prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a practitioner or pharmacy",
      "provinceRecordPublisher": "Nova Scotia Pharmacy Regulator",
      "provinceRecordUrl": "https://www.nspharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/canada-provinces#nova-scotia",
      "provinceGuideUrl": "https://peptidelocal.com/locations/nova-scotia",
      "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries"
    },
    {
      "recordId": "pl-canada-province-vyleesi-ontario",
      "compound": "VYLEESI",
      "compoundSlug": "vyleesi",
      "compoundAliases": [
        "bremelanotide",
        "Vyleesi",
        "PT-141",
        "NDA 210557",
        "melanocortin receptor agonist",
        "Vyleesi by country",
        "bremelanotide medicine",
        "bremelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA-approved US medicine record",
      "province": "Ontario",
      "provinceSlug": "ontario",
      "searchQuery": "VYLEESI in Ontario",
      "boundedAnswer": "VYLEESI in Ontario begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Ontario, open Find a pharmacy or pharmacy professional from Ontario College of Pharmacists and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi",
      "identitySourceLabel": "Current VYLEESI prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or pharmacy professional",
      "provinceRecordPublisher": "Ontario College of Pharmacists",
      "provinceRecordUrl": "https://ocpinfo.com/public/how-to-use-find-a-pharmacy-or-pharmacy-professional/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/canada-provinces#ontario",
      "provinceGuideUrl": "https://peptidelocal.com/locations/ontario",
      "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries"
    },
    {
      "recordId": "pl-canada-province-vyleesi-prince-edward-island",
      "compound": "VYLEESI",
      "compoundSlug": "vyleesi",
      "compoundAliases": [
        "bremelanotide",
        "Vyleesi",
        "PT-141",
        "NDA 210557",
        "melanocortin receptor agonist",
        "Vyleesi by country",
        "bremelanotide medicine",
        "bremelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA-approved US medicine record",
      "province": "Prince Edward Island",
      "provinceSlug": "prince-edward-island",
      "searchQuery": "VYLEESI in Prince Edward Island",
      "boundedAnswer": "VYLEESI in Prince Edward Island begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Prince Edward Island, open Find a pharmacy or registrant from Prince Edward Island College of Pharmacy and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi",
      "identitySourceLabel": "Current VYLEESI prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy or registrant",
      "provinceRecordPublisher": "Prince Edward Island College of Pharmacy",
      "provinceRecordUrl": "https://pepharmacists.ca/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/canada-provinces#prince-edward-island",
      "provinceGuideUrl": "https://peptidelocal.com/locations/prince-edward-island",
      "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries"
    },
    {
      "recordId": "pl-canada-province-vyleesi-quebec",
      "compound": "VYLEESI",
      "compoundSlug": "vyleesi",
      "compoundAliases": [
        "bremelanotide",
        "Vyleesi",
        "PT-141",
        "NDA 210557",
        "melanocortin receptor agonist",
        "Vyleesi by country",
        "bremelanotide medicine",
        "bremelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA-approved US medicine record",
      "province": "Quebec",
      "provinceSlug": "quebec",
      "searchQuery": "VYLEESI in Quebec",
      "boundedAnswer": "VYLEESI in Quebec begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Quebec, open Find a pharmacist from Ordre des pharmaciens du Québec and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi",
      "identitySourceLabel": "Current VYLEESI prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacist",
      "provinceRecordPublisher": "Ordre des pharmaciens du Québec",
      "provinceRecordUrl": "https://www.opq.org/trouver-un-pharmacien/",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/canada-provinces#quebec",
      "provinceGuideUrl": "https://peptidelocal.com/locations/quebec",
      "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries"
    },
    {
      "recordId": "pl-canada-province-vyleesi-saskatchewan",
      "compound": "VYLEESI",
      "compoundSlug": "vyleesi",
      "compoundAliases": [
        "bremelanotide",
        "Vyleesi",
        "PT-141",
        "NDA 210557",
        "melanocortin receptor agonist",
        "Vyleesi by country",
        "bremelanotide medicine",
        "bremelanotida"
      ],
      "evidenceLane": "FDA-approved medicine",
      "identityStatus": "Product-specific FDA-approved US medicine record",
      "province": "Saskatchewan",
      "provinceSlug": "saskatchewan",
      "searchQuery": "VYLEESI in Saskatchewan",
      "boundedAnswer": "VYLEESI in Saskatchewan begins with a medicine identity, but Canadian authorization belongs to an exact product, DIN, company, presentation, route, status, and regulated supply path. A shared ingredient name does not transfer that record to every listing. For a pharmacy, professional, clinic, or seller claim involving Saskatchewan, open Find a pharmacy from Saskatchewan College of Pharmacy Professionals and match the legal name, address, record type, current status, product category, and claimed supply route. Then check the exact product or ingredient separately in Health Canada's Drug Product Database. A provincial record does not authorize a product, and a federal product record does not validate a different seller or shipment.",
      "reviewedDate": "2026-07-20",
      "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi",
      "identitySourceLabel": "Current VYLEESI prescribing information",
      "identitySourcePublisher": "National Library of Medicine, DailyMed",
      "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf",
      "provinceRecordLabel": "Find a pharmacy",
      "provinceRecordPublisher": "Saskatchewan College of Pharmacy Professionals",
      "provinceRecordUrl": "https://saskpharm.ca/site/find-a-pharmacy",
      "productRecordLabel": "Drug Product Database",
      "productRecordPublisher": "Health Canada",
      "productRecordUrl": "https://health-products.canada.ca/dpd-bdpp/search?lang=eng",
      "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/canada-provinces#saskatchewan",
      "provinceGuideUrl": "https://peptidelocal.com/locations/saskatchewan",
      "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries"
    }
  ]
}